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VECTOR-BORNE DISEASES: 
STUDIES IN HUMAN WEST NILE VIRUS INFECTION  
AND CANINE LYME NEPHRITIS 
PATRICK CONOR CARNEY 
Boston University School of Public Health, 2017 
Major Professor: Sherri O. Stuver, Sc.D., Clinical Professor of Epidemiology 
ABSTRACT 
Vector-borne diseases are a resurgent focus in public health.  As concern 
about climate change mounts, the close relationship between these diseases and 
the environment has garnered growing attention.  This dissertation examines the 
relationship between environment and vector-borne disease in both human and 
veterinary medical contexts and on both a local and national scale.   
The first study investigated using a novel Internet-based surveillance system 
for risk mapping of West Nile Virus (WNV) in the contiguous United States from 
2007–2014, with meteorological, demographic, and land use variables as 
predictors.  The study found that annual average temperature, minimum 
temperature, precipitation, and human population density were predictive of WNV 
reports, but that the novel surveillance data appeared to have systematic gaps 
that impair the utility of the model.   However, the results may help to guide 
improvements in novel surveillance systems. 
The second study used the logistic regression model developed in the first 
study to predict the risk of WNV in the contiguous United States in 2050 and 
 x 
2070 under four projected climate scenarios.  The study found that Southern 
California is likely to remain the area of greatest risk under all scenarios and that 
risk would be expected to increase across much of the West under the scenario 
of uncontrolled carbon dioxide emissions.  The results of this study may inform 
development of more sophisticated models and may help to direct public health 
resources to areas of greatest impact. 
The third study investigated the relationship between cases of canine Lyme 
nephritis and precipitation in the months prior to diagnosis.  Precipitation three 
months prior to diagnosis was found to be associated with the development of 
Lyme nephritis (hazard ratio for 1 inch/month 1.125, 95% confidence interval 
1.009 – 1.254).  This finding may improve diagnostic accuracy for dogs with 
protein-losing nephropathies and may guide studies of additional risk factors.  
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1. Introduction 
Vector-borne diseases (VBDs) are a substantial public health threat, 
accounting for 17% of the global infectious disease burden.1  Prior to the 
discovery of the role of arthropod vectors in disease, human morbidity and 
mortality from VBDs exceeded that from all other causes combined.2,3  Ronald 
Ross’s 1897 finding that mosquitos served to transmit malaria, and the ensuing 
flurry of identification of other VBDs, represented one of the great leaps in public 
health.4,5  That diseases could be minimized and even prevented by targeting 
vectors opened a vast new avenue for public health interventions, and officials 
were quick to begin implementing such measures.6–10 Vector control programs 
virtually eliminated malaria from the United States; facilitated global trade and 
travel by enabling construction of the Panama Canal and by opening up to the 
world regions previously held hostage by high VBD burdens; and, dramatically 
reduced infectious disease incidence worldwide.11–16   
Vector control programs peaked in the mid-twentieth century with massive 
projects to drain wetlands and widespread spraying of potent new insecticides 
like dichlorodiphenyltrichloroethane (DDT).7,12,17  In much of the latter half of the 
century, vector control efforts waned due to a combination of the emergent 
environmental movement spearheaded by Rachel Carson’s indictment of DDT, 
developing vector resistance to pesticides, enhanced wetlands protections, and 
successes of prior vector control.18–21  Research and public health funding were 
redirected to other concerns, like cardiovascular disease, cancer, and HIV/AIDS, 
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2 
that assumed greater prominence as the risk of VBDs appeared to diminish.3,22 
The reprieve proved to be short-lived, and in the late twentieth century 
VBDs underwent a resurgence that continues in the present.3,23  The success of 
vector control programs enabled much of the global movement of goods and 
people that, paradoxically, now serves to introduce both vectors and the 
diseases they carry to naïve populations around the globe.24  The broad reach 
and speed of air travel has compounded the situation by removing some of the 
barriers to vectors surviving across long distances.25  Air travel also ensures that 
an infected individual can reach their destination before a disease has become 
clinically apparent, increasing the chances of them serving as a reservoir host 
capable of introducing the pathogen into native vectors.26,27  Examples of 
emerging transnational VBD threats abound.  West Nile Virus (WNV) was 
introduced to the United States in 1999, likely from air travel from the Middle 
East, and rapidly became endemic across North America.28,29  Chikungunya 
became established in the Western Hemisphere in 2013, spreading across much 
of South and Central America and intermittently establishing a toehold on the 
United States mainland.30–33  Zika virus appears to have island-hopped across 
the Pacific Ocean from Southeast Asia to South America, reaching Brazil by 
2015 and expanding across the continent and making inroads into North 
America.34–37   
Changes in climate and climate volatility have also contributed to the 
resurgence of VBDs in the past few decades.38  A general warming trend may be 
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leading to expansion of vectors into more extreme latitudes and altitudes, while 
changes in precipitation may be driving the development of epidemic foci.38–45  
Milder winters in many regions permit overwintering of hosts and vectors, 
increasing the local pathogen load and expanding the seasonality of some 
diseases.38  Large-scale meteorological phenomena that may become more 
prevalent or intense with climate change — e.g., hurricanes and typhoons, 
droughts, and the El Niño-Southern Oscillation — have the potential to drive 
substantial change in the dynamics of VBDs locally, regionally, and globally.46–50 
Persistence of a VBD in any locale is entirely dependent upon the 
presence of sufficient densities of competent vectors and reservoir/amplifying 
hosts.51,52  The geographic distribution of disease vectors is therefore a primary 
determinant of disease occurrence.52–57   However, for many VBDs, other risk 
factors are incompletely described or poorly understood.  Moreover, human 
migration patterns, population densities, global and regional climates, and 
intermediate/secondary host distributions appear to be changing at an 
accelerating rate, which is likely to change the distribution of competent vectors 
and the VBDs they transmit.42,44,49,58–61 Our understanding of VBD dynamics, and 
hence our capacity to plan for and react to changing patterns of VBD occurrence, 
depends on our ability to identify important risk factors and to comprehend their 
impacts.38  For VBDs with few or no known risk factors, a key aim of research 
must be the identification of risk factors and their associated effects on VBDs.  
For VBDs with a relatively well-elaborated set of risk factors, research is 
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increasingly focused on understanding how changing one or more factors 
changes VBD disease ecology. 
Mathematical modeling has been used extensively for investigating 
VBDs.62–85   Most modeling of VBDs attempts to replicate observed patterns of 
disease occurrence and, if successful, to examine the impact of altering some 
component(s) of the system such as vector density, vector mortality, vector 
sensitivity to meteorological variables, host density, host feeding site density, and 
host mortality.  A growing body of modeling studies examines the effects of 
climate on vectors and on VBD occurrence, with output often in the form of 
predictive risk mapping.86–95  Such studies have been performed to make 
predictions in endemic regions as well to determine whether a currently non-
endemic region might be at risk of endemicity under probable future climate 
scenarios.  
WNV has been explored in a number of models, with often conflicting 
results.43,96–100  The disparity generally arises from differing mathematical terms 
used to describe reservoir-vector interaction.101  Nonetheless, modeling has 
become a valuable tool for investigating the complex dynamics of WNV, both as 
a means of identifying potential risk factors and as a means of predicting the 
effects of varying certain factors on disease occurrence.  Geographically large-
scale modeling has been facilitated by the ready availability of high-quality, high-
resolution meteorological, demographic, and satellite-based land cover data on 
the Internet.102,103  The Internet has also enabled development of real-time 
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disease surveillance systems, which may offer benefits of timeliness and 
automation over traditional surveillance methods.104–108  However, few studies 
have examined the use of these alternative surveillance systems for modeling. 
Study 1 uses WNV data from HealthMap, a largely automated Internet-
based aggregator of disease reports for a variety of diseases, and attempts to 
replicate the observed pattern of WNV reports in the United States between 2007 
and 2014 from a variety of meteorological, demographic, and land cover 
predictors.106  A model that accurately replicates observed data would indicate 
that modeling using Internet-based surveillance may provide a new avenue for 
investigating the dynamics of WNV and, possibly, other VBDs.  A model that fails 
to replicate the HealthMap data might provide insights into limitations of novel 
surveillance methods, and might also indicate opportunities for improving such 
methods.109 
Study 2 takes the model developed in Study 1 and applies it to a variety of 
predicted future climate and demographic scenarios.  The impact and distribution 
of VBDs are frequently extremely sensitive to meteorological inputs, meaning 
that future patterns of disease may be very different from the present in the face 
of climate change.50,110  Understanding how the pattern of a disease like WNV 
may change in the future is essential for public health planning and may provide 
important information for climate change policy as well.111  Study 2 utilizes 
climate scenarios from the Intergovernmental Panel on Climate Change’s Fifth 
Assessment Report, combined with estimates of population from the United 
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Nations Department of Economic and Social Affairs Population Division’s 2015 
Revision of World Population.48,112  The model output is presented in the form of 
choropleth risk mapping, providing an intuitive visual representation of future 
WNV risk in the United States under low, medium, and high carbon dioxide 
emissions trajectories in 2050 and 2070. 
Study 3 hypothesizes that precipitation is a risk factor for the development 
of Lyme nephritis in dogs, a severe and poorly understood protein-losing 
nephropathy (PLN) with only one known risk factor, breed.113  Identification of 
additional risk factors may facilitate better clinical discrimination of Lyme nephritis 
patients and may also enable the development of predictive models of the 
disease.  Most prior studies have been case series, with one case-control 
analysis using dogs with non-Lyme-associated PLN as controls.114–117  The lack 
of a gold standard for diagnosis of Lyme nephritis makes such control selection 
problematic, as misclassification of outcome is likely.118  Study 3 uses a case-
crossover design to circumvent these difficulties and shows that this study design 
may be applicable to more conditions than previously considered.   
The studies presented here are intended to further our understanding of 
the impact of risk factors on VBDs of human and veterinary importance through 
modeling of novel surveillance data, predictive modeling with risk mapping, and 
expansions of the application of case-crossover design to non-acute outcomes 
and to companion animal medicine.    
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2. Spatiotemporal modeling of West Nile Virus in the United States 
2.1 Introduction 
West Nile Virus (WNV) was first identified in blood sampled from a woman 
in northwestern Uganda in 1937 during the course of an epidemiologic study to 
define the geographic extent of yellow fever virus.119–121  Genome sequencing 
has identified at least five distinct lineages, which correspond with distinct 
geographic points of identification.122–125  Lineage 1 is the most widespread and 
contains the most within-lineage heterogeneity; lineage 2 is endemic to Africa 
with extension into Europe; lineage 3 is an apparently rare isolate from eastern 
Europe with no documented pathogenicity; lineage 4 is endemic to Russia; and, 
lineage 5 is endemic to India, with an atypical pediatric predilection. 
Similar to other members of Flaviviridae, WNV is transmitted by mosquito 
vectors, particularly Culex spp.126  The genus Culex is diverse, including at least 
770 species, but within the United States Culex pipiens, Culex tarsalis, and Culex 
quinquefasciatus appear to be the most important vectors for WNV transmission 
to humans.127–131  WNV has additionally been detected in 62 other mosquito 
species within the United States, including species outside the Culex genus; 
while some may serve a role in transmission between birds and non-mammalian 
species, the importance of many of these non-Culex vectors is largely unknown 
but likely minimal.129,132  Only birds are substantial reservoir hosts capable of 
amplifying the virus and thus serving as a source of infection for naïve 
mosquitoes feeding upon them, with all other animals representing secondary or 
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dead-end hosts incapable of continuing the viral cycle.133  Crows (genus Corvus), 
house sparrows (Passer domesticus), house finches (Carpodacus mexicanus), 
and blackbirds (Turdus merula) appear to be favored by many Culex species and 
hence play a prominent reservoir role in the United States.26,134–138  The 
transmission cycle therefore involves Culex mosquitoes feeding upon 
passerines, with repeated feedings on birds perpetuating the virus within 
reservoir species and feedings upon secondary/dead-end hosts producing 
infection in humans, horses, or other vertebrates.  
Following inoculation by the bite of an infected mosquito, disease may 
develop within three to 14 days.139  The majority of human WNV infections are 
inapparent.140,141  Up to 25% of infections produce a non-specific febrile 
illness.141,142   Fatal central nervous system disease, often called neuroinvasive 
WNV, is a rare outcome.143  Treatment is purely supportive and symptomatic.  
While vaccines have been used for prevention of WNV-related illness in horses 
since 2002, there are currently no commercially available human vaccines.144  A 
hydrogen peroxide-inactivated whole-virus vaccine intended for human use 
entered Phase 1 clinical trials in late 2015.145 
Serologic surveys in the 1940s and 1950s showed that WNV was endemic 
across eastern, central, and southern Africa at the time of or shortly after its 
discovery.146–148  WNV began to appear outside of Africa in the 1950s, with one 
case noted in Israel in 1951 and several cases in the ensuing two years.149,150  
Europe’s first seropositive report came from Albania in 1958, but clinical disease 
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was not seen until 1962, when an epidemic of neuroinvasive cases cropped up in 
France.151,152  In Australia, WNV was isolated for the first time in 1960.153  
Seropositivity was found in India and southeast Asia by the early 1960s, while 
China appeared free of the disease until the late 1980s.154–156   
In 1999, WNV was found to be the cause of several human cases of 
encephalitis in the New York City area, representing the first documented cases 
arising in the United States.28  A concurrent die-off of passerines was observed, 
and studies linked the two events.136,157  The initial outbreak resulted in 59 
human cases and seven fatalities.28  WNV has since become endemic to North 
America, with rapid spread across the continent.  By the end of 2015, the 
Centers for Disease Control and Prevention (CDC) had recorded a total of 
20,265 human cases of neuroinvasive disease due to WNV since its introduction 
to the United States; 23,672 cases of non-neuroinvasive disease; and 1,911 
deaths.158  Studies suggest that unusually high temperatures contributed to an 
increase in the number of cases in 2012, highlighting the importance of climate in 
determining WNV occurrence.45,159  
To better understand the dynamics of WNV occurrence in the United 
States, models have been developed using WNV surveillance data from the 
Centers for Disease Control and Prevention (CDC).97,160  The overarching goal of 
these models is to identify and measure the impact of important disease 
predictors, and to use this information to produce short-term (e.g., the following 
year) and long-term (e.g., mid to late 20th century) predictions about disease 
10 
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incidence.97,160  Predictors employed in these models typically include 
meteorological variables and, occasionally, a presence/absence indicator for 
mosquito vectors, but other variables that have been identified as important 
predictors of WNV infection in mosquitoes, such as land cover, are rarely 
included.  While CDC data likely represent the most comprehensive surveillance 
dataset available, issues of data access may present a challenge for developing 
reliable models that predict short-term disease incidence.  There is typically a 
12–14 month lag until WNV surveillance data are made available for research, 
and access to data can be further impaired by bottlenecks in acquisition 
procedures and personnel, particularly in the face of other high-profile epidemics 
like Zika virus.  Based on current lag times in data availability, a model seeking to 
predict WNV risk for the ensuing year would not be able to include data from the 
most recent 1–2 years.  Given the relatively short period of time in which WNV 
has been endemic to the United States, this information might provide valuable 
augmentation of model performance.   
Non-traditional infectious disease surveillance systems have recently been 
identified as having the potential to offer a faster route to data acquisition, which 
could translate to inclusion of more recent data and faster model development, 
and  hence more accurate and timely public health interventions.107  HealthMap, 
developed by a group at Boston Children’s Hospital, is one such surveillance 
system, providing real-time alerts for a variety of diseases including WNV.106  It is 
an Internet-based passive surveillance system that constantly monitors a large 
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number of local, national, and international governmental and media Websites for 
disease reports.  These reports are largely autonomously digitally curated by 
proprietary HealthMap algorithms, with a final layer of human review.  The 
system is designed to provide rapid and accurate capture and public 
dissemination of disease reports, with more efficient use of human resources.   
In this study, HealthMap data for WNV in the contiguous United States 
were used to develop a model of WNV occurrence, with meteorological, land 
cover, and population variables as predictors.  The primary aim of the study was 
to attempt to replicate HealthMap data using variables that have been shown to 
be associated with WNV or other VBDs, in order to demonstrate whether 
HealthMap data may be amenable to modeling in a manner similar to CDC data.  
HealthMap data have been used in modeling diseases that cause acute 
outbreaks like Ebola, Zika virus, and measles.162–164  A secondary aim is to make 
a qualitative comparison between HealthMap data and CDC data: modeling with 
HealthMap data has substantial utility only if it can be used as a reasonable 
proxy for CDC or other gold standard data.  If HealthMap data are not amenable 
to the same type of modeling as CDC data, it would be important to understand 
what structural differences might exist between the two data sources that could 
explain the lack of concordance, because the efficiency and timeliness benefits 
of HealthMap are only relevant if the data offer a level of quality that facilitates 
real-world applications.  If HealthMap data do prove amenable to modeling in this 
manner, it would allow for application of HealthMap-derived models for 
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investigation of future WNV risk under differing meteorological and demographic 
scenarios. 
2.2 Methods 
2.2.1 Study Design 
 This study used a multiple logistic regression design to model the 
probability of WNV reports in the contiguous United States between 2007 and 
2014.  The basic unit on which analysis was performed was county or the 
statistical equivalent of a county (e.g., parish in Louisiana).  The outcome of 
interest was the presence or absence of WNV reports.  For each year of the 
study, a county was considered “positive” (coded as 1) if there was at least one 
HealthMap report of WNV within that county in the given year, and “negative” 
(coded as 0) if there were no HealthMap reports.  Each county was therefore 
represented in the dataset one time per year, with a total of eight 0/1 values per 
county.   
Exposures included in the model were meteorological variables, land 
cover, and population density.  The meteorological variables used in this analysis 
were identified as significant predictors of the probability of WNV cases occurring 
within a county in a previous modeling study using CDC data.  These included 
the  annual bias-adjusted mean monthly maximum temperature (“maximum 
temperature”), annual bias-adjusted mean monthly minimum temperature 
(“minimum temperature”), the annual average of the bias-adjusted mean monthly 
maximum and minimum temperatures (“average temperature”), annual total 
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precipitation (“precipitation”), and total precipitation of the coldest quarter.  
Temperature variables required bias adjustment to account for variability in the 
time of observation, quality of weather station instrument siting, and changes in 
weather station instrumentation or siting. 
Land cover was selected as a predictor based on findings from studies 
that identified certain habitats as being preferred by mosquito vectors, avian 
hosts, or both, as well as studies showing predictive value in a variety of vector-
borne diseases.75,165–167  The percentage of a county’s total surface area covered 
by water was included as a separate continuous predictor for similar reasons.  
Human population, which has previously been demonstrated to be a predictor of 
WNV case probability, was included in the form of population density.97  Density 
was used rather than total population, both because of the marked variation in 
county size across the U.S. and the more biologically appropriate characteristics 
of density when modeling disease transmission.  For example, Kings County in 
New York and Dallas County in Texas have similar total populations of just over 
2.5 million people, but population density in the geographically smaller Kings 
County is over 14 times greater.168 
2.2.2 West Nile Virus Report Identification 
 West Nile Virus incident data from January 1, 2007, through August 31, 
2014 were obtained from HealthMap.org 
(http://www.healthmap.org/en)/Epidemico (http://www.epidemico.com), an 
Internet-based, partially automated aggregator of infectious disease reports via a 
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variety of reporting entities.  The design characteristics of HealthMap allow for 
real-time surveillance and visualization of disease trends around the world, 
potentially reducing the time lag and human resource-intensive requirements of 
traditional surveillance methods.  Sources utilized by HealthMap are primarily 
news media and governmental public health bodies, including ProMED Mail, the 
World Health Organization, the European Centre for Disease Prevention and 
Control’s EuroSurveillance program, Google News, and Chinese online news 
aggregators Baidu News and SOSO Info.106  These sources are continuously 
monitored by HeathMap, and content is automatically filtered and organized 
according to disease, species, date of report, and geographic locale, typically at 
the state, county, or municipality level.  Reports are edited algorithmically and 
manually by HealthMap staff to remove redundancies due to multiple sources 
reporting the same story.  Each data row in a HealthMap dataset includes 
information on location (both place name and map coordinates), species 
involved, disease name, the report headline, and a summary, typically the first 
one to three sentences of the report.   
Three versions of the HealthMap data were evaluated: 1) unfiltered except 
for removal of reports outside of the contiguous United States (“least strict”); 2) 
moderately filtered, in which reports were limited to those involving humans 
within the contiguous United States, and excluding reports of WNV absence and 
ambiguous reports that could not be clarified due to unavailability of the original 
source material (“moderate”); and 3) a more restrictive set of reports removing 
15 
 
	
15 
clear duplicates from the moderate set (“strictest”).  Reports of WNV outside of 
the contiguous United States were removed by filtering on place name, followed 
by manual review of the report headline and summary.  Non-human reports were 
removed by filtering on species and then by a similar manual review.  Reports of 
diseases other than WNV and clear duplicates were removed via manual review.   
When the species, disease, or location was uncertain following manual review, 
the full original report was located via multiple Internet searches using Google’s 
search algorithm with the headline or first sentence(s) of the summary entered as 
search terms.  If the original report could not be located, the report was then 
excluded from analysis.  Reports on the absence of WNV from a locale were 
excluded based on a manual review.   
In the strictest dataset, duplicates were retained only when the report 
referenced either multiple cases in one locale or single cases in multiple locales, 
provided the geocoding of the reports accurately reflected one of those 
scenarios.  An example of the first scenario would be duplicate reports of either 
one or two cases in County A, both georeferenced to County A: both reports 
would be retained if there were two cases reported, whereas one report would be 
removed if both reports referenced the same single case.  An example of the 
second scenario would be duplicate reports of one case each in counties A and 
B: both reports would be retained if the geocoding of the first report localized to 
County A and the second to County B, but one report would be removed if the 
geocoding of both reports localized to County A only.  Duplicate reports could be 
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either multiple identical copies of the same report, or non-identical reports of 
unambiguously identical case(s).  For duplicates in which the geocoding occurred 
at differing levels (i.e., state and county, state and municipality, or municipality 
and county), the county was the retained record if available, followed by the 
municipality if the county was not available.  State was retained only if more 
accurate geocoding was unavailable.  Reports in which potential duplication was 
unclear or partial/overlapping were retained.   
WNV incident reports were assigned to the U.S. county or statistical 
equivalent Federal Information Processing Standard designation (FIPS, a unique 
five digit code established by the U.S. Census Bureau) using a Web-based 
reverse geocoding application programming interface (API) maintained by the 
Federal Communications Commission (https://www.fcc.gov/general/census-
block-conversions-api).169  Each FIPS was then associated with an internal point 
within the county, which served as the point of analysis in each county.  The 
internal point was the geographic center (centroid) unless the county shape was 
such that the centroid fell outside of the county boundaries; in those rare 
instances, the internal point was the point within the county boundaries closest to 
the centroid.170  Entries where the geocoding was at the state level were 
assigned to the county at the geographic center of the state (e.g., a report 
geocoded “California” would be assigned to Madera County, California).   
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2.2.3 Creation and Definition of Predictor Variables 
The meteorological variables were collected by weather stations 
maintained by or affiliated with the National Atmospheric and Oceanic 
Administration (NOAA), and records were obtained from the National Climatic 
Data Center (https://www.ncdc.noaa.gov/cdo-web).  This dataset contains hourly, 
daily, and monthly summaries from approximately 1,600 quality-controlled 
weather stations across the United States.  Each county internal point was linked 
to the geographically closest weather station by implementation of a form of 
Vincenty’s formulae, and data from that station were used to calculate the 
associated county’s meteorological values.  Vincenty’s formulae calculate 
distances between two geographic points based on an idealization of the Earth’s 
surface as an oblate spheroid (flattened or tangerine-shaped, as opposed to 
olive-shaped [prolate] or a perfectly rounded sphere).171  Maximum temperature 
was calculated by averaging the maximum temperature of each month for a 
given year.  Minimum temperature was similarly calculated.  Average 
temperature was calculated as the mean of maximum temperature and minimum 
temperature for a given year.  Precipitation was calculated by summing 
precipitation across all 12 months of the year.  Total precipitation of the coldest 
quarter was calculated by dividing each year into three-month quarters (January–
March, April–June, July–September, and October–December), calculating the 
average temperature for each quarter similar to the description for annual 
average temperature above, selecting the quarter with the coldest average 
18 
 
	
18 
temperature, and summing the monthly precipitation totals within the selected 
quarter. 
Land cover data for 2006 and 2011 were obtained from the U.S. Multi-
Resolution Land Characteristics Consortium’s National Land Cover Database 
(NLCD); the 2006 data were used for 2007–2010, and the 2011 data were used 
for 2011–2014 (http://www.mrlc.gov/finddata.php).  The National Land Cover 
Database uses information from the Landsat 7 and 8 Earth-orbiting satellites to 
generate high-resolution maps of the United States based on eight (Landsat 7) or 
11 (Landsat 8) spectral bands.102  A spectral band is essentially a camera tuned 
to a specific wavelength or range of wavelengths of light, and each type of land 
cover produces a characteristic pattern of reflectance across the bands.  The 
NLCD records land cover as a nominal variable with 16 categories applicable to 
the contiguous United States (Appendix 1).  Land cover for each county was 
extracted from the NLCD data as the predominant land cover at the coordinates 
of the county internal point.  Open water was chosen as the reference category.  
The percentage of a county covered in water (“percent water”) was calculated as 
water area divided by total (land plus water) area using data from the United 
States Census Bureau.  
Population data were obtained from the United States Census Bureau as 
county-level estimates of total population from 2007 through 2014.  Estimates for 
2007–2009 were derived from the 2000 decennial census 
(http://www.census.gov/popest/data/intercensal/county/county2010.html), while 
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estimates for 2010–2014 were derived from the 2010 decennial census 
(http://www.census.gov/popest/data/counties/totals/2015/CO-EST2015-
alldata.html).  The U.S. Census Bureau also provides data on the land area and 
water area of each U.S. county or county equivalent 
(http://www.census.gov/geo/maps-data/data/gazetteer2015.html).  Population 
density was calculated by dividing the county population estimate by the land 
area of the county.   
2.3 Analysis 
A logistic regression model was chosen to model the probability of human 
West Nile Virus reports based on the structure of the HealthMap data.  The 
majority of reports were geocoded to the county level, with smaller numbers 
geocoding to the state or municipal level.  Reports at the municipal level were 
able to be assigned to the appropriate county, but those at the state level could 
not be properly assigned and were instead assigned to the county at the 
geographic center of the state.  Due to an already sparse dataset, reports with 
only state level geocoding information were retained, recognizing that some 
misclassification of exposure might occur but that exposure is often relatively 
uniform within a state.  This assumption is likely more valid for small states with 
minimal elevation change and minimal latitudinal spread.  However, retention of 
these cases might create spurious “hot spots” of reports at the geographic center 
of states, making any count-based regression model (e.g., linear regression or 
zero-inflated beta regression) poor choices.  Conversely, a report for a given 
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county might reference numerous cases, but the report itself would constitute 
only a single data point, resulting in effective undercounting; again, count-based 
regression techniques would be poor options.  Logistic regression permitted 
retention of reports at the state level, but was not as susceptible to over- or 
under-counting when compared to linear or beta regression. 
Pre-analysis data manipulation utilized the pandas library and the NumPy 
extension in the Python programming language.  The data were randomly 
divided into a training dataset comprising two thirds of the data and a validation 
dataset of the remaining third, stratified on presence/absence of WNV reports to 
ensure adequate representation in both datasets.  Dividing the dataset by years 
(e.g., training on data from 2007–2013, and validating on 2014) was considered 
as an alternative, but was not utilized because qualitative evaluation of the data 
suggested that the HealthMap data improved over the time period under study.  
Figure 1 shows the division of the study dataset into six subsets: a training and a 
validation dataset, each of which was in turn divided into a least strict, moderate, 
and strictest dataset.  The strictest training data were used to fit a logistic 
regression model in SAS, with presence/absence of WNV reports as the 
outcome.  The model was initially fit with all covariates, and then stepwise, 
backward, and forward selection were employed to determine which predictors to 
retain in the model using an alpha level of 0.05.  The process was repeated with 
all two-way interactions (exclusive of land cover) included.   
Logistic regression models were fit using a penalized likelihood approach 
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(Firth’s method) to reduce bias associated with sparse data.172  Model fit was 
assessed by calculation of R2, maximum-rescaled R2, the Hosmer-Lemeshow 
goodness-of-fit test, and Stukel’s goodness-of-fit test.173–176  R2 was calculated 
as: 
R2 = 1 – exp{2[logL(M) – logL(0)]/n} 
where logL(M) is the maximized log likelihood for the fitted model, logL(0) is the 
maximized log likelihood for the model containing no covariates (intercept only), 
and n is the sample size.  It therefore represents the additional information 
provided by the covariates compared to the null model.  However, the upper limit 
of this R2 value is below one, making it not entirely comparable to R2 in linear 
regression.  The maximum-rescaled R2 corrects this: 
 R2max = R2 / [1 – exp(2*log(0)/n)] 
The R2 measures can be thought of as indicators of the model’s predictive 
power, whereas the goodness-of-fit statistics can be thought of as indicators of 
whether the model under consideration could be improved by the addition of 
interaction terms, changing the linearity of predictor variables, and/or changing 
the link function.177 
Once the covariates and interaction terms had been selected, three 
parallel models were evaluated using those covariates as applied to the least 
strict, moderate, and strictest training datasets.  The PROC LOGISTIC 
statements used to generate the models included a SCORE option, which 
applied the model parameters derived from the training datasets to the 
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corresponding validation datasets.  These scored validation datasets were used 
to generate receiver operating characteristic (ROC) curves for comparison 
between the three datasets.  The strictest dataset was used as the target for the 
ROC curves given that it likely minimizes outcome misclassification.  The final 
model for analysis was selected based on evaluation of the ROC curves.  
Predicted probabilities for the occurrence of WNV reports for the scored 
validation dataset with the best ROC were then mapped, using ordinary kriging to 
interpolate and smooth values on the map, to provide a representation of the 
probability of WNV reports from 2007–2014 within the contiguous United States.  
A sub-analysis was performed to compare model performance between the early 
years of HealthMap’s development (2007–2009) and later years (2010–2014). 
2.4 Results 
During the study period, there were a total of 3107 counties or statistical 
equivalents in the contiguous United States, resulting in 24856 outcomes 
available for evaluation (i.e., 3107 counties each represented annually over 8 
years).  The least strict dataset contained 6337 WNV reports from 779 unique 
counties between 2007 and 2014.  Using an annual presence/absence indicator 
for WNV reports in a county, there were 1823 positives (i.e., at least one report 
within the county) and 23033 negatives over the course of the study period.  The 
greater number of positives compared to unique counties indicates that some 
counties were positive in multiple years.  The moderate dataset contained 2127 
reports from 473 unique counties, with 899 positives and 23957 negatives.  The 
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strictest dataset contained 1810 reports from 470 unique counties, with 849 
positives and 24007 negatives.  Annual report counts, positive county counts, 
and total counts for the study period are presented in Table 1.  Compared to the 
least strict dataset, the moderate dataset contained 66% fewer reports and 51% 
fewer positive counties, while the strictest dataset contained 71% fewer reports 
and 53% fewer positive counties.  This observation indicates that the moderate 
and strictest datasets differed substantially from the least strict but minimally from 
each other.  Therefore, only the least strict and strictest datasets were used for 
the majority of the analysis.  The years 2007 and 2009 had the fewest reports 
and positive counties, while 2013 had the highest number.  
Report counts and positive county counts by state are presented in Table 
2, with CDC case counts by state for comparison 
(http://www.cdc.gov/westnile/statsmaps/final.html).  There appears to be general 
agreement between HealthMap data and CDC data with respect to states with 
the highest incidence of West Nile Virus (e.g., California, Texas) and those with 
the lowest incidence (e.g., Arkansas, Delaware, the District of Columbia, Maine).  
However, many upper Midwestern and non-coastal Western states are 
underrepresented in the HealthMap data.  This level of agreement is also seen in 
Figure 2, which presents annual incidence maps by county, with CDC maps for 
comparison (http://diseasemaps.usgs.gov/mapviewer).  Coastal areas with high 
incidence and very low incidence show agreement, but the upper Midwest and 
non-coastal West, which had high incidence in 2007 and 2013 and a moderate 
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incidence in most other years, are not well represented by HealthMap data.  
Figure 1 also suggests a temporal trend in HealthMap’s ability to capture reports 
corresponding to CDC data, with improvement over the course of the study 
period.  
2.4.1 Model Fitting Using the Strictest Dataset 
Based on the strictest data set, the logistic regression model fit with all 
predictors (land cover, total annual precipitation, maximum temperature, 
minimum temperature, average temperature, precipitation of the coldest quarter, 
percent water, and population density) yielded the same model regardless of 
selection technique (backwards, forwards, or stepwise).  Retained variables 
included total annual precipitation, minimum temperature, average temperature, 
land cover, and population density.  The model R2 was 0.0163, with a maximum-
rescaled R2 of 0.0644.  The Hosmer and Lemeshow goodness-of-fit test 
(p=0.0108) suggested that the model might benefit from inclusion of interaction 
terms; Stukel’s goodness-of-fit test was performed to confirm this (p<0.0001).   
Interactions between average temperature and total annual precipitation, 
average temperature and minimum temperature, minimum temperature and 
population density, and population density and total annual precipitation were 
found to be significant when the model was fit with all two-way interactions 
exclusive of land cover.  This model yielded minimal to no improvement in 
goodness-of-fit statistics (Hosmer and Lemeshow p=0.038, Stukel’s p<0.0001) 
and minimal improvement in R2 (0.0194) and maximum-rescaled R2 (0.0777).   
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2.4.2 Model Fitting Using the Least Strict Outcome 
The logistic regression model with the predictors and interaction terms 
identified in the model selection based on the strictest outcome was applied to 
the least strict outcome, for comparison.  Model performance, while still 
suboptimal, was improved with respect to the Hosmer and Lemeshow goodness-
of-fit test (p=0.3635), R2 (0.0375), and maximum-rescaled R2 (0.093).  The 
Stukel’s goodness of fit test still suggested inadequate fit (p<0.0001).   
2.4.3 Validation and Final Model Selection 
The areas under the curve for the  ROC curves of the models using the 
three outcome datasets (strict, moderate, and least strict) showed comparable 
performance in predicting the probability of counties with WNV reports (Figure 3).  
In agreement with the poor goodness of fit test statistics, the areas under the 
curve for the three models (ranging from 0.6715 to 0.6846) indicated only poor to 
fair discrimination of positive counties.  
Based on the improvement in goodness-of-fit and the equivalent ROC 
areas under the curve, the model using the least strict dataset was selected for 
final modeling.  This decision was largely a function of practical considerations: 
one proposed benefit of using HealthMap data for model formulation is rapid data 
availability and automation of data processing; generating the moderate and 
strictest datasets proved to be both time- and labor-intensive, negating much of 
that benefit.   
Odds ratio estimates and 95% confidence intervals for average 
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temperature, precipitation, minimum temperature, and population density in the 
final model are presented in Table 3.  For each one degree Fahrenheit increase 
in average temperature, the odds of at least one WNV report in a county 
decreased by 11.3%.  Each additional inch of precipitation decreased the odds 
by 1.4%.  For minimum temperature, the odds increased 8.8% for each one 
degree Fahrenheit increase, and increasing population density by 100 people per 
square kilometer increased the odds by 7.9%.  Land cover was a significant 
predictor of the odds of WNV reports (p<0.0001), with forested areas, scrubland, 
and pasture land having a protective effect. 
The predicted probabilities for WNV reports in the contiguous United 
States for the period 2007–2014 are presented in Figure 4.  The probability was 
predicted to be greatest in the western portion of the country, particularly in the 
Southwest, and lowest in the Plains states, Midwest, Southeast, and northern 
New England.  The Mid-Atlantic region, Lower Peninsula of Michigan, and 
southern Texas had moderate probabilities of WNV reports.  Consistent with both 
the CDC data and the HealthMap data (Figure 1), southern California (San 
Bernardino County) had the greatest predicted probability of WNV.  The model 
correctly identified north-central Colorado (Larimer and Weld counties) and 
southeastern Oregon (Malheur County)/southwestern Idaho (Owyhee County) as 
areas of higher risk, but it appeared to severely underestimate the risk across 
much of the western Upper Midwest/non-coastal upper West and overestimated 
risk in Michigan and the mid-Atlantic region.  Risk also appears to have been 
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overestimated in the coastal Pacific Northwest.   
The underestimation of risk across the western Upper Midwest/non-
coastal upper West is likely due to underreporting of WNV in this region in the 
HealthMap data (Figure 2).  This underreporting may be a reflection of changes 
in HealthMap’s ability to capture cases over the course of the study period: the 
region had the greatest number of reports in 2007, when HealthMap was in its 
infancy and least likely to correctly capture cases.  However, such an explanation 
is not entirely adequate, as the region also experienced a high number of cases 
in 2013, when HealthMap was somewhat more reliably identifying cases in many 
other regions of the country but again failed to highlight the disease in less 
populous northern states.  To explore this possibility further, the data were 
divided into two categories by time period: 2007–2009, representing the years 
when the algorithm for capturing cases in the form of reports may have been 
undergoing rapid development, and 2010–2014, representing the years when the 
algorithm had likely had sufficient time to mature.  While somewhat arbitrary, the 
chosen cut-point between 2009 and 2010 was based on visual inspection of 
Figure 1, which shows that the extent of concordance between HealthMap and 
CDC surveillance on an annual basis appears to improve between 2009 and 
2011.  The final model was then applied to both subsets, and measures of fit 
were evaluated.   
Despite the apparent improvement in HealthMap’s ability to capture WNV 
reports over the course of this study, measures of fit were similar for both time 
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periods.  For 2010–2014, the Hosmer and Lemeshow statistic (p = 0.0027), R2 
(0.0415), and maximum-rescaled R2 (0.0862) indicated that the model as applied 
to more recent data was no better than, and potentially worse than, the model 
applied to data from early in HealthMap’s development (2007–2009: Hosmer and 
Lemeshow, p=0.0648; R2, 0.0282; maximum-rescaled R2, 0.129).  This suggests 
that the overall model’s poor performance is due to something other than using 
data from early versions of HealthMap.   
To further evaluate the model’s performance, the results were compared 
to a model of WNV risk developed by Harrigan et al. (2014) using CDC data and 
a similar set of predictors for the years 2003–2011.97  Those investigators utilized 
an ensemble modeling approach in which the results of nine separate models 
were weighted according to model performance based on areas under the ROC 
curves ranging from 0.542 to 0.935.  Although not directly comparable, the ROC 
of the present study appears to fall within the low range of the models evaluated 
by Harrigan et al. Figure 5 presents a choropleth map of that study’s measure of 
WNV risk (probability of WNV presence in vectors) for the period 2003–2011.  
Rough concordance between the risk probabilities based on our models (Figure 
4) with those based on the CDC models (Figure 5) also can be seen in the 
increased WNV risk from Southern California across to southern Texas, in the 
mid-Atlantic states, and in southern Michigan/northern Indiana and Ohio. 
although the Harrigan et al. model does a much better job of predicting risk 
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across the northern plains states and around the Mississippi River delta, it seems 
to overestimate the risk in Florida.   
2.5 Discussion 
 The rapid expansion of Internet-based dissemination of information poses 
an opportunity to augment traditional methods of disease surveillance.106,107,178  
While traditional methods are likely to remain the gold standard for the 
foreseeable future, unique features of Internet-based surveillance offer potential 
advantages of timeliness and increased automation, reducing both the lag in data 
availability and the resources required to acquire and process the data.   
 In this study, we used Internet-based surveillance data on WNV reports to 
generate a model that attempted to reproduce the pattern of WNV cases in the 
United States between 2007 and 2014.  Predictors evaluated in the model 
included meteorological variables identified as significant predictors of WNV risk 
in a previous modeling study, and population and land cover variables with high 
biologic plausibility as predictors.  In contrast to expectation, the model 
demonstrated limited ability to accurately reproduce HealthMap data for the 
selected time period within the contiguous United States.  Southern California 
was correctly identified as the area with the greatest risk of WNV reports, and 
most of the United States east of the Mississippi River was correctly identified as 
having low risk.  However, substantial overestimation of risk was seen in the Mid-
Atlantic states, and even greater underestimation was noted in the western 
Upper Midwest/non-coastal upper West.   
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 Consistent with previous studies, precipitation was inversely correlated 
with the probability of WNV reports.39,97,179  Drought conditions are strongly 
associated with increased WNV risk, with multiple proposed complimentary 
mechanisms.180  Drought may concentrate avian hosts around fewer and smaller 
water sources, increasing the chances of interaction with mosquitoes carrying the 
virus.  Moreover, in many droughts, the remaining water sources tend to be the 
types of artificial pools and irrigated landscapes characteristic of areas of higher 
human population density, resulting in more chance for mosquito-human 
interaction.181  Finding these water sources can take a mosquito longer in a 
drought, giving the virus more time to complete its 15- to 21-day incubation within 
the mosquito.  An infected female with ready access to water in which to lay her 
eggs may go through her entire reproductive lifespan so quickly that she dies 
before the virus has a chance to become transmissible, whereas a female in 
drought conditions may wait weeks to find a suitable spot.181  Although mosquito 
larvae require water to develop, increased precipitation may paradoxically impair 
mosquito populations.  Water rich in organic matter aids in larval development, 
and the flushing action of frequent rainfall dilutes out and washes away organic 
material.180  Predators that might otherwise keep Culex populations in check, 
such as frogs or dragonflies, may themselves be adversely affected by low 
rainfall.182  The relationship between precipitation and WNV may be a large 
contributor to the model’s identification of southern California, in the midst of a 
record-setting drought for much of the study period, as the highest-risk area in 
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the United States.182 
 Previous studies have identified mild winters as a risk factor for human 
WNV cases, and this observation is borne out by our finding that increasing 
minimum temperature was associated with an 8.8% increase in the odds of a 
county having at least one WNV report.97,183  Mild winters may maximize 
overwintering survival of female Culex mosquitoes and non-migratory avian 
hosts, which may be particularly important for WNV-infected mosquitoes, whose 
survival, in some circumstances, may be reduced compared to uninfected 
females.184–188  This survival penalty might ostensibly be exacerbated by extreme 
conditions, such that unusually cold winters select for survival of uninfected 
females.  Mild winters might then yield a surviving population relatively enriched 
in infected females. 
 The inverse effect of average temperature on the odds of WNV reports 
seen in our model contradicts some previous studies.  The discrepancy may be 
rooted, at least partly, in mosquito population dynamics as applied to the specific 
time period utilized in this study.  Most studies show that increased temperatures 
promote rapid development of Culex larvae, resulting in greater numbers of 
mosquitoes and more generations of mosquitoes produced per year.43,189,190  
However, the survival of mosquitoes based on temperature assumes a negative 
relationship, with higher temperatures resulting in higher mortality.190,191  The 
differential actions of these factors results in effective mosquito numbers 
(population density) assuming a roughly negative quadratic (parabolic) form with 
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respect to temperature: the number of mosquitoes increases with increasing 
temperature up to a point as the effects on reproductive cycling dominates, but 
further increases in temperature result in fewer mosquitoes as impaired survival 
begins to dominate.  The United States had higher than average temperatures 
for every year in the study period except 2008, making it possible that the 
relationship captured is largely on the right side of the parabola.192  This type of 
non-linearity was not explored in the current model.  Future efforts would include 
analysis using general additive models, which permit exploration of the shape of 
covariate-outcome relationships.193   
 Human population density was positively correlated with the odds of WNV 
reports, which is in agreement with the theory that drought concentrates vectors 
and avian hosts in areas of higher population density.180  Increased population 
density also means that a single infected mosquito, which typically lives out its 
lifespan within 0.2–3.0 kilometers of its birthplace, can come into contact with, 
and feed on, a greater number of humans.194–196  Previous studies have used 
total population as a predictor, which logically is positively associated with finding 
WNV cases—increasing the denominator will almost invariably increase the 
number of cases identified—but which has a less biologic interpretation.97  
However, it is important to note that vector-borne diseases may be less 
straightforwardly related to the effects of population density than are directly 
communicable diseases, because transmission is mediated via passage through 
multiple species rather than human-to-human contact.   
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 Despite the positive association between population density and the odds 
of WNV reports, land cover types associated with high population density were 
not predictive of WNV reports.  One possible explanation for the lack of a clear 
trend is that the data used for land cover are extremely fine-grained, with 30-
meter resolution, which may actually introduce substantial misclassification of 
exposure in more developed areas.  Any given square 30 meters on a side is 
very likely to fall within the predominant land cover in a very rural county—
evergreen forest in northern Maine or cropland in rural Kansas, for example—
whereas, the highly fragmented landscapes of developed areas mean that the 
internal point has a reasonably high probability of falling on a park (resulting in 
misclassification as forest or grassland) or other land cover types inconsistent 
with the true prevailing land cover.  The resulting misclassification would be 
differential with respect to population density and would tend to bias results 
towards the null in areas of higher population density. 
 The model developed in this study showed poor performance based on 
measures of fit and a qualitative (visual) comparison with CDC data.  Poor fit of 
the model suggests that variables commonly used to model WNV or VBD risk 
may not provide adequate predictive ability when applied to HealthMap data, 
while lack of comparability to CDC data suggests HealthMap may have 
systematic biases in data collection.  The sub-analysis based on early versus 
later HealthMap data suggested that immaturity of HealthMap’s algorithm in the 
early years was not responsible for the poor model fit.  Other possibilities include 
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inappropriate model choice, inclusion of inappropriate predictors, failure to 
include appropriate predictors, or failure of HealthMap data to capture the 
relationships the modeling is attempting to reflect.   
 Inappropriate model choice suggests that the outcome, predictors, or both 
assume a form within the model that is not consistent with the true association 
between exposure and outcome.  The relationship between average temperature 
and the odds of WNV reports, as discussed above, might fall into this category.  
Inclusion of average temperature as a quadratic form might improve model fit, 
but would also complicate interpretation of the odds ratio.  If the intent of a study 
is purely predictive modeling (i.e., a “black box” approach), the specific 
contributions of individual predictors may be considered unimportant relative to 
the overall model output, making interpretation of the odds ratio less critical, but 
even within this context readily interpretable odds ratios contribute to 
understanding of the model.  Understanding the model is arguably a prerequisite 
for determining the validity of the model’s output.  The more opaque the 
interpretation of a model’s parameters, the more difficult it is to know the model is 
measuring what it is intended to measure.   
 Logistic regression was chosen as the model form for this study due to 
perceived pitfalls of the HealthMap data with respect to both geolocation at the 
state level only and under- and over-counting of cases.  Reports geocoded to the 
state level only could have been excluded, resulting in loss of information, or 
included, resulting in potential misclassification of exposure.  Moreover, including 
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these reports would result in over-counting of cases in the counties at the 
geographic centers of affected states.  The choice of logistic regression was 
intended to retain some of the information encoded in these reports, without 
granting the geographic centers of states undue influence in a count-based 
regression model.  However, logistic regression itself entails significant loss of 
information, since all reports within a county were collapsed to a single binary 
outcome.  Counties with large numbers of reports have the same influence as 
those with only a single report.  To a limited extent, including multiple years in the 
analysis may ameliorate this loss of information, as counties with high WNV 
burdens are more likely to be positive in multiple years than counties with low 
WNV burdens.  Regardless, this loss of information may have impaired model fit. 
   Inclusion of inappropriate predictors is considered less probable as a 
contributor to the poor model fit.  All potential predictors included in the model 
have biologic plausibility as modifying or contributing to WNV risk, and several 
have been found to be predictive in a prior study with a well-fitting model.97   
Omission of appropriate predictors is much more plausible, particularly the 
omission of a presence/absence indicator for mosquito species identified as 
vectors.  This variable has been included in similar studies, but was omitted here 
for several reasons.  First, an examination of the distribution of Culex mosquitoes 
capable of transmitting WNV in the contiguous United States found essentially 
complete coverage, such that virtually every county would be “positive” for 
mosquitoes.197  A binary variable that assumes only one value in a study cannot 
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contribute to a model.  Second, inclusion of mosquito species as a binary 
variable suffers from the same loss of information as was discussed with respect 
to WNV reports.  Species mapping of mosquitoes merely indicates where 
mosquitoes have or have not been found, often over years or even decades of 
surveillance, such that a county with a single Culex mosquito in 1970 would carry 
the same weight as a county with extraordinarily high concentrations of Culex 
during the time period under consideration in the present study.  Third, the model 
was developed partly with the goal of predicting future WNV risk, and modeling of 
future mosquito populations to input into the WNV model would depend heavily 
on the same suite of predictors used for the WNV model itself.  Any uncertainty in 
the future mosquito distribution estimates would thus be effectively magnified in a 
model using those estimates.  This leads to perhaps the strongest argument for 
omitting mosquito distribution as an input: the predictors used in the WNV model, 
and in most previous WNV models, are already largely attempting to replicate 
mosquito population dynamics.  Minimum temperature and annual precipitation, 
for example, are mainly significant for their impact on mosquito populations and 
dynamics.  Effects on other organisms involved in WNV transmission—the virus 
itself, passerine hosts, or humans—are of comparably lesser importance.  Even 
a variable that would superficially seem to have nothing to do with mosquito 
populations, like human population density, may attempt to extract information 
about the interaction of humans and mosquitoes.   
That being said, exclusion of a presence/absence indicator of mosquitoes 
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in an unpublished sub-analysis by Harrigan et al. resulted in a slight reduction in 
model fit, which was thought to be due to misclassification of exposure 
secondary to travel.  The investigator speculated that cases that contracted 
disease in a locale with mosquitoes but were diagnosed in a locale with no 
mosquitoes introduced misclassification, which could be partially rectified by the 
inclusion of the mosquito presence/absence indicator.  The magnitude of this 
effect is unclear but likely small, and it is improbable that the potential gain in 
model fit with inclusion of a mosquito presence/absence indicator would 
necessarily outweigh the considerations that resulted in its exclusion from this 
study or result in substantial improvement in model fit. 
A substantial deficiency in our model is likely related to the failure of 
HealthMap data to reflect the relationships the model is attempting to capture.  If 
the model attempts to predict WNV reports based on meteorological variables or 
biologic/ecologic variables but the HealthMap data are instead largely a function 
of other phenomena, poor model fit would be the expected outcome.  The fact 
that such occurred is strongly suggested by consistent underreporting in North 
Dakota (22 HealthMap reports versus 657 CDC-reported cases between 2007 
and 2014), South Dakota (33 versus 699), Wyoming (7 versus 263), Nebraska 
(31 versus 891), and Montana (4 versus 257).  At the opposite end of the 
spectrum, the predicted case reports in Rhode Island (6 versus 8), New 
Hampshire (2 versus 3), Vermont (4 versus 6), and Maine (6 versus 1) show that 
other regions were very well represented.  Maine, with only one CDC-reported 
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case, would influence the analysis roughly as strongly as Wyoming, with 263 
cases; this effect would be further magnified by the choice to model the outcome 
as dichotomous.  Such differential reporting is extremely unlikely to have 
biological, ecological, or meteorological underpinnings.  Some of the differential 
reporting may be due to media fatigue, in which a protracted news event like a 
WNV epidemic garners progressively less coverage.198  A review of the reports 
included in the HealthMap data confirms this possibility, as the most common 
type of report is of the “first case of West Nile Virus reported in location X” 
variety.  This phenomenon explains why states with the lowest case counts often 
have the most complete coverage.  However, the explanation breaks down when 
looking at states with larger numbers of cases.  For example, media fatigue alone 
cannot account for the discrepancies between the western Upper Midwest/non-
coastal upper West and other locales with high WNV incidence.   
Given the media sources trawled by HealthMap, it may be that some of 
the problem stems from a lack of news coverage in areas with underreporting of 
cases (Figure 6).199  The percentage of land area with no local newspaper 
distribution is highest in Arkansas, Kansas, the Dakotas, and northern 
Minnesota, and a large percentage of Montana is covered by only one local 
newspaper.  Over-saturated media markets may account for certain areas of 
overestimation, such as the mid-Atlantic, the Chicago environs, and Michigan’s 
Lower Peninsula.  Further analysis could evaluate the model stratified on “high 
media” and “low media” by state to get some sense of the magnitude of this 
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effect, but the Media Deserts Project has not yet made these data available. 
Individual public health authorities in each state may also play a role in the 
variable capture of cases by HealthMap.  Many reports in areas with small 
numbers of WNV cases are actually reports of WNV-infected mosquitoes trapped 
as part of a public health monitoring program, not of human cases.  This 
occurrence seems to be a reflection of regional differences in mosquito 
surveillance, as New England states are overrepresented in these reports.  It 
may be that other states do not have mosquito surveillance programs or do not 
routinely report their findings.  The latter is supported by the finding that several 
heavily affected states have issued press releases announcing that they will no 
longer report on mosquito surveillance.  Similarly, there may be regional 
differences in press release guidelines.  Some public health agencies may not 
issue press releases for WNV cases, may issue them only for neuroinvasive or 
fatal cases, or may issue releases to media outlets not monitored by HealthMap.   
This study has several important limitations.  First, as previously noted, 
the choice of logistic regression resulted in a loss of information, and not all other 
potential model structures (e.g., a count-based model with weighting based on 
the level of geocoding) were evaluated.  Future investigation would involve 
exploring the shape of predictor-outcome relationships through general additive 
models, possibly with application of these results in a conditional autoregressive 
model. 
Second, the model did not account for spatial or temporal correlation, 
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which may substantially affect (typically underestimate) the standard errors for 
independent variables and hence the decision of which variables to retain in the 
model.200  With the larger standard errors expected with a correlated data 
analysis, some variables included in the present model may have been excluded.  
Along the same lines, estimates of effect for independent variables in the present 
study likely have artificially narrow confidence intervals.200  However, it is not 
necessarily unusual to retain statistically non-significant predictors that have 
biologic plausibility or that have been shown to be significant in previous studies, 
and all variables in the present study meet one or both criteria.  Additionally, 
standard errors may be less important in purely predictive models, as opposed to 
models that seek to quantify the effect of a single predictor on an outcome.  A 
similar logistic regression model without explicit incorporation of spatial 
autocorrelation has been shown to accurately reproduce the risk of canine 
heartworm disease in the United States, for example.201   
Third, the model developed in this study is predicting the probability of 
WNV reports in HealthMap, which is assumed to be a proxy for the gold standard 
of CDC-reported cases.  The model can be no better than the data on which it is 
based, and the study demonstrates substantial gaps in HealthMap’s ability to 
capture WNV cases.  Further analysis to determine the relationship between 
CDC data and HealthMap data might take the form of developing and comparing 
parallel models. 
In conclusion, this study found that HealthMap data could not be 
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accurately replicated with the chosen predictors and model structure.  The model 
developed here may provide some utility in predicting WNV risk in the contiguous 
United States, but the outcome data utilized present challenges that may 
preclude accurate forecasting of all but the highest- and lowest-risk areas.  In 
particular, large and apparently geographically systematic gaps in HealthMap’s 
ability to mirror WNV incidence were identified, resulting in at best fair predictive 
ability of the model.  The benefits of timeliness and reduced manual data 
processing offered by HealthMap or other Internet-based automated surveillance 
systems may be valuable for rapid development of models, provided 
stakeholders are aware that such models may provide only crude predictive 
ability.  Their utility is likely greatest for emergent diseases or unusual outbreaks 
of endemic diseases that receive prominent and consistent media coverage.  Our 
study suggests that more nuanced and accurate models for endemic diseases 
should probably be formulated using traditional surveillance data for the 
foreseeable future, but that Internet-based automated surveillance may 
contribute complimentary or preliminary information that could help to guide near-
term public health interventions. 
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Table 1. Annual West Nile Virus positive county counts and reports for the contiguous 
United States as reported in HealthMap data, 2007–2014 
Year 
Positive 
counties 
(least 
strict) 
Number of 
reports 
(least 
strict) 
Positive 
counties 
(moderate) 
Number of 
reports 
(moderate) 
Positive 
counties 
(strictest) 
Number of 
reports 
(strictest) 
2007 39 206 30 105 30 103 
2008 119 233 58 87 53 73 
2009 91 165 31 47 25 36 
2010 167 358 98 167 92 146 
2011 263 794 107 194 102 169 
2012 336 1480 186 539 181 473 
2013 502 2135 258 676 246 560 
2014 306 966 131 312 120 250 
Total 1823 6337 899 2127 849 1810 
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Table 2.  2007–2014 West Nile Virus positive county counts and reports by U.S. state for the “Least strict” 
and “Strictest” HealthMap data sets, with CDC case counts for comparison   
State 
Number of positive counties 
(%) Number of reports or cases (%) 
  Least strict Strictest Least strict Strictest CDC 
Alabama 15 (0.8) 10 (1.2) 28 (0.4) 15 (0.8) 123 (0.7) 
Arizona 30 (1.7) 19 (2.2) 67 (1.1) 33 (1.8) 769 (4.3) 
Arkansas 5 (0.3) 1 (0.1) 6 (0.1) 2 (0.1) 136 (0.8) 
California 192 (10.5) 93 (11.0) 1070 (16.9) 255 (14.1) 2865 (16.1) 
Colorado 55 (3.0) 37 (4.4) 173 (2.7) 75 (4.1) 1409 (7.9) 
Connecticut 23 (1.3) 13 (1.5) 113 (1.8) 27 (1.5) 63 (0.4) 
Delaware 10 (0.6) 3 (0.4) 29 (0.5) 4 (0.2) 15 (0.1) 
District of Columbia 4 (0.2) 2 (0.2) 12 (0.2) 5 (0.3) 45 (0.3) 
Florida 49 (2.7) 25 (2.9) 103 (1.6) 50 (2.8) 142 (1.2) 
Georgia 29 (1.6) 18 (2.1) 68 (1.1) 24 (1.3) 219 (1.2) 
Idaho 32 (1.8) 14 (1.7) 89 (1.4) 19 (1.0) 289  (1.6) 
Illinois 130 (7.1) 40 (4.7) 422 (6.7) 88 (4.9) 672 (3.8) 
Indiana 81 (4.4) 35 (4.1) 150 (2.4) 49 (2.7) 164 (0.9) 
Iowa 22 (1.2) 15 (1.8) 41 (0.6) 22 (1.2) 149 (0.8) 
Kansas 27 (1.5) 19 (2.2) 332 (5.2) 28 (1.5) 308 (1.7) 
Kentucky 17 (0.9) 6 (0.7) 32 (0.5) 7 (0.4) 45 (0.3) 
Louisiana 44 (2.4) 31 (3.7) 162 (2.6) 89 (4.9) 661 (3.7) 
Maine 6 (0.3) 5 (0.6) 19 (0.3) 6 (0.3) 1 (0.0) 
Maryland 16 (0.9) 8 (0.9) 28 (0.4) 13 (0.7) 136 (0.8) 
Massachusetts 58 (3.2) 20 (2.4) 463 (7.3) 46 (2.5) 67 (0.4) 
Michigan 29 (1.6) 10 (1.2) 70 (1.1) 26 (1.4) 337 (1.9) 
Minnesota 22 (1.2) 13 (1.5) 43 (0.7) 23 (1.3) 295 (1.7) 
Mississippi 44 (2.4) 43 (5.1) 202 (3.2) 166 (9.2) 649 (3.7) 
Missouri 21 (1.2) 15 (1.8) 34 (0.5) 16 (0.9) 172 (1.0) 
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Montana 9 (0.5) 4 (0.5) 21 (0.3) 4 (0.2) 257 (1.4) 
Nebraska 42 (2.3) 21 (2.5) 76 (1.2) 31 (1.7) 891 (5.0) 
Nevada 21 (1.2) 8 (0.9) 56 (0.9) 15 (0.8) 81 (0.5) 
New Hampshire 15 (0.8) 2 (0.2) 35 (0.6) 2 (0.1) 3 (0.0) 
New Jersey 51 (2.8) 17 (2.0) 127 (2.0) 25 (1.4) 119 (0.7) 
New Mexico 22 (1.2) 14 (1.7) 45 (0.7) 24 (1.3) 214 (1.2) 
New York 80 (4.4) 39 (4.6) 354 (5.6) 75 (4.1) 412 (2.3) 
North Carolina 8 (0.4) 4 (0.5) 15 (0.2) 7 (0.4) 23 (0.1) 
North Dakota 15 (0.8) 13 (1.5) 46 (0.7) 22 (1.2) 657 (3.7) 
Ohio 40 (2.2) 15 (1.8) 102 (1.6) 21 (1.2) 222 (1.2) 
Oklahoma 24 (1.3) 18 (2.1) 76 (1.2) 45 (2.5) 426 (2.4) 
Oregon 25 (1.4) 3 (0.4) 37 (0.6) 3 (0.2) 88 (0.5) 
Pennsylvania 123 (6.8) 31 (3.7) 477 (7.5) 44 (2.4) 142 (0.8) 
Rhode Island 13 (0.7) 4 (0.5) 48 (0.8) 6 (0.3) 8 (0.0) 
South Carolina 11 (0.6) 6 (0.7) 16 (0.3) 7 (0.4) 49 (0.3) 
South Dakota 23 (1.3) 18 (2.1) 61 (1.0) 33 (1.8) 699 (3.9) 
Tennessee 21 (1.2) 9 (1.1) 71 (1.1) 18 (1.0) 134 (0.8) 
Texas 122 (6.7) 88 (10.4) 544 (8.6) 286 (15.8) 2985 (16.8) 
Utah 21 (1.2) 5 (0.6) 46 (0.7) 5 (0.3) 117 (0.7) 
Vermont 14 (0.8) 3 (0.4) 35 (0.6) 4 (0.2) 6 (0.0) 
Virginia 31 (1.7) 5 (0.6) 43 (0.7) 7 (0.4) 68 (0.4) 
Washington 39 (2.1) 9 (1.1) 92 (1.5) 14 (0.8) 60 (0.3) 
West Virginia 14 (0.8) 3 (0.4) 19 (0.3) 4 (0.2) 14 (0.1) 
Wisconsin 67 (3.7) 8 (0.9) 118 (1.9) 13 (0.7) 111 (0.6) 
Wyoming 11 (0.6) 7 (0.8) 21 (0.3) 7 (0.4) 263 (1.5) 
TOTAL 1823 (100.3) 849 (100.4) 6337 (100.2) 1810 (99.7) 17780 (100.5) 
Positive counties are counties with at least one report of West Nile Virus.  "Least strict" refers to the HealthMap dataset unedited except 
for removal of reports outside of the contiguous United States; "Strictest" refers to the dataset edited to remove non-human reports, 
ambiguous reports, reports of WNV absence, and clear duplicates
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Table 3. Odds ratios and 95% confidence intervals for predictors of the probability of 
West Nile Virus reports in the contiguous United States, 2007–2014 
Predictor Units 
Odds 
ratio 
95% CI  
(lower, upper) 
Average temperature Degrees F 0.887 (0.872, 0.904) 
Precipitation Inches 0.986 (0.982, 0.991) 
Minimum temperature Degrees F 1.088 (1.075, 1.102) 
Population density 100 people per square km 1.079 (1.060, 1.098) 	
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Figure 1.  Structure of the data used to develop the model of WNV report 
probability for each county in the contiguous United States  
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Figure 2. Annual WNV incidence by county (positive/negative) for the contiguous United States based on 
HealthMap report counts data (left; least strict dataset) and CDC case counts data (right; images from 
http://diseasemaps.usgs.gov/mapviewer/)   
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Figure 3.  Receiver operating characteristic curve (ROC) comparing models 
fitted using the strictest (blue), moderate (red), and least strict (all cases; green) 
datasets   
 
"All cases" refers to the least strict HealthMap dataset, unedited except for 
removal of reports outside of the contiguous United States; “Moderate cases” 
refers to the dataset edited to remove non-human reports, ambiguous reports, 
and reports of WNV absence; and "Strictest cases" refers to the dataset edited to 
remove non-human reports, ambiguous reports, reports of WNV absence, and 
clear duplicates. 	
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Figure 4.  Map of predicted WNV report probability for the contiguous United 
States based on HealthMap data, 2007–2014  
 
Red=high probability, yellow and green = intermediate probability, blue = low 
probability. 
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Figure 5.  Probability of WNV reports in vectors for the contiguous United States 
between 2003–2011, based on a composite of nine models.  From Harrigan et al. 
(2014) 
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Figure 6. Number of daily newspapers in the United States by zip code. From: 
https://mediadeserts.wordpress.com/state-maps-2, accessed 9/1/2016 
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3. Predictive modeling of West Nile Virus In the United States under varying 
projected climate and demographic scenarios 
3.1 Introduction 
 The interplay between the environment and the incidence of human cases 
of West Nile Virus (WNV) has been explored in a number of studies.45,97,160,161  
WNV survival, reproductive success, geographic distribution and density, and 
viral load of the mosquito vectors and, to a lesser extent, avian hosts involved in 
WNV transmission are sensitive to changes in environmental inputs like 
precipitation and temperature.180,202  Models incorporating these inputs seek to 
replicate patterns of WNV occurrence, allowing for greater understanding of how 
changes in environmental variables might impact the human WNV disease 
burden.96  Information gained from these models can help to direct public health 
policy, including better temporal and spatial targeting of vector control, vector and 
host surveillance, human case surveillance, and preventive measures.111  Such 
model-driven interventions may have applications in the short term (weeks to 
months), intermediate term (one to several years), or long-term 
(decades).97,107,160  An understanding of and ability to predict the future values of 
disease risk is critical to the use of models in public health responses to WNV. 
 The accuracy of most meteorological predictions rapidly degrades over 
time, making it difficult to reliably project meteorological phenomena beyond a 
few days to weeks.203  Even predicting precipitation or average temperature for 
the next year is notoriously difficult and often inaccurate.  There are too many 
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unforeseen contingencies, like volcanic eruptions, that could dramatically alter 
the weather.  However, it is important to distinguish between the weather, which 
is what is experienced at any given moment or year, and climate, which is the 
long-run average of weather.  Daily, weekly, monthly, and even yearly variation in 
weather patterns may be hard to predict, but weather averaged over the course 
of many years displays distinct trends, and these trends are amenable to 
modeling.204,205  Similarly, while the predicted values of climate models may not 
be an accurate reflection of weather for a specific year, they are intended to be 
representative of the overall trends in weather: for example, a model that predicts 
climate in 2050 is not necessarily intended to predict the weather in 2050 per se, 
but rather to represent a reasonable expectation of the average weather (i.e., 
climate) for some period of years spanning 2050.   
 The potential for humans to impact global climate was first suggested by 
Fourier in 1827, who noted that the Earth should be much colder than it actually 
was unless the atmosphere somehow acted to retain heat.206  The heat-retaining 
properties of gases were further elaborated in the mid-century by John Tyndall, 
and in 1896 Svante Arrhenius made the first explicit connection between the 
burning of fossil fuels, release of carbon dioxide into the atmosphere, and the 
potential for global warming.207,208  Concerns about carbon dioxide-induced 
climate change were subsequently dismissed by scientists who thought that any 
excess carbon dioxide would be absorbed by the oceans.209  The idea 
consequently stalled until the 1960s, when an obscure publication from 1957 
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demonstrating that the oceans do not absorb as much carbon dioxide as 
previously thought was combined with newer evidence that atmospheric carbon 
dioxide was rapidly increasing.210,211   
 Atmospheric carbon dioxide concentration is thought to act as a primary 
driver of global climate by increasing radiative forcing, which is the difference 
between insolation (energy from the Sun received by Earth) and energy radiated 
back to space from Earth.  Certain gases including carbon dioxide are radiatively 
active, meaning that they are capable of altering the magnitude of radiative 
forcing by either trapping energy at or near Earth’s surface (positive forcing) or 
increasing the amount of energy radiated back into space (negative forcing).  
Carbon dioxide has a moderate trapping effect, which is posited to result in 
positive forcing.212  Human activities, particularly the burning of fossil fuels, have 
resulted in an increase in atmospheric carbon dioxide since the beginning of the 
Industrial Revolution, and anthropogenic carbon dioxide release is expected to 
continue throughout at least the twenty-first century.211,213   
 Since the “re-discovery” of climate change science in the mid-twentieth 
century, the field has developed rapidly to encompass a number of interrelated 
fields—physical chemistry, geology, meteorology, paleontology, physics, 
oceanography, hydrology, etc.—that highlight the extraordinary complexity of 
climate.  In 1988, the World Meteorological Organization and the United Nations 
Environment Program chartered the Intergovernmental Panel on Climate Change 
(IPCC) to evaluate and summarize the findings of climate change science; to 
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bring together experts in the field to synthesize models of future climate; and, to 
make recommendations for limiting the extent of climate change, mitigating its 
consequences, or adjusting to climate change.214  The IPCC has released five 
Assessment Reports at five- to seven-year intervals to update predictions based 
on new information and improved modeling capabilities.  The fifth report (IPCC 
AR5) was released in 2013 and 2014.48  Uncertainties in estimates of future 
carbon dioxide emissions related to factors such as population growth, 
alternative fuel utilization, and industrialization of currently low industrialized 
countries have led to the generation of multiple predicted emissions trajectories, 
which have in turn been used to model multiple predicted future climate 
scenarios. 
 The aim of the present study is to apply the model of WNV risk developed 
for the contiguous United States in Study One to an array of future climate and 
demographic scenarios.  WNV risk, like that of many VBDs, is strongly influenced 
by meteorological inputs, raising the possibility of changes in the geographic 
distribution of risk under conditions of climate change.180  It is also affected by 
population density, and predicted changes in both the total population of the 
United States and in the distribution of that population might similarly alter the 
geographic pattern of risk.  Understanding how patterns of disease are likely to 
change in the future permits proactive public health planning, and may also 
inform strategies for mitigating climate change and associated impacts.  A finding 
that projected climate changes result in a dramatic increase in WNV risk, for 
60 
 
	
60 
example, might provide additional support for more aggressive carbon dioxide 
emissions targets.   
The present study utilized data from the IPCC AR5, along with estimates 
of future human population growth, to model the risk of WNV in the contiguous 
United States in both 2050 and 2070.  Climate predictions based on four different 
carbon dioxide emissions trajectories were evaluated at both time points to 
provide estimates of the predicted risk under low emissions, moderate emissions 
(two scenarios), and high emissions.  
3.2 Methods 
3.2.1 Study Design 
 Predictions of West Nile Virus risk for the contiguous United States in 
2050 and 2070 under four different climate scenarios were generated using a 
logistic regression model for predicting the probability of at least one report of 
West Nile Virus occurring in a given county.  The model, presented in Study One, 
was developed and validated using West Nile Virus reports aggregated by 
HealthMap, an online aggregator of disease reports, between 2007 and 2014.106  
The model generated probability estimates for each United States county or 
administrative equivalent at an internal point, defined as the geographic center 
(centroid) of the county or, for counties in which the geographic center fell 
outside the boundaries of the county, as the point inside the county boundaries 
closest to the centroid as calculated by the United States Census Bureau.170   
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3.2.2 Creation and Definition of Predictor Variables 
 Five predictor variables were used as inputs for the model: mean monthly 
minimum temperature (“minimum temperature”), the average of the mean 
monthly maximum and minimum temperatures (“average temperature”), total 
annual precipitation (“precipitation”), population density by county, and land 
cover.  In Study One, minimum temperature and population density were found 
to be positively correlated with the risk of WNV reports, such that increases in the 
predictors resulted in increased risk of WNV, while maximum temperature and 
annual precipitation were negatively correlated with the risk of WNV reports.  
Odds ratios and 95% confidence limits for the predictors are presented in Table 3 
of Study One. 
 Meteorological predictor variables for the model were obtained from 
WorldClim.org (www.worldclim.org), which takes climate predictions from global 
climate models presented in the IPCC AR5 report and converts them to spatially 
referenced data sets of the predicted climate at a fine scale (i.e., a grid with units 
of 30 arc-seconds, or just under 1 km).103  Spatially referenced data connect 
each variable value/entry to a geographic location, typically using coordinates.  
The WorldClim data are available for two future time points, 2050 and 2070, with 
four different climate scenarios at each time point.  The four scenarios are 
derived from four projected atmospheric greenhouse gas concentration 
trajectories over the course of the twenty-first century, representing a low 
estimate, a high estimate, and two mid-range estimates.48  The low trajectory 
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was developed under the assumption that emissions peak in the current decade, 
while the high trajectory uses an assumption that emissions continue to increase 
throughout the century.  The two mid-range scenarios are based on the 
assumption that emissions peak sometime in the mid-century.  For each 
scenario, WorldClim.org provides estimates of average temperature, minimum 
temperature, and precipitation.  The values of these variables for each county in 
the contiguous United States for 2050 and 2070 were extracted from the grid 
cells corresponding with the county internal point.  Mean, minimum, and 
maximum values for the predictor variables by year and emissions scenario are 
presented in Table 4. 
Land cover data for 2011 were obtained from the U.S. Multi-Resolution 
Land Characteristics Consortium’s National Land Cover Database (NLCD; 
http://www.mrlc.gov/finddata.php).102  Land cover for a county was extracted from 
the NLCD data as the predominant land cover at the coordinates of the county 
internal point.  The NLCD records land cover as a nominal (categorical) variable 
with 16 categories applicable to the contiguous United States (Appendix 1).  
Open water was used as the reference category.   
Population data by county were extrapolated from the U.S. Census 
Bureau’s estimates of U.S. county populations in 2015 
(http://www.census.gov/popest/data/index.html).  Total U.S. population estimates 
for the years 2050 and 2070 were obtained from the United Nations Department 
of Economic and Social Affairs Population Division’s 2015 Revision of World 
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Population (https://esa.un.org/unpd/wpp/Download/Standard/Population).112  The 
difference between the estimated total U.S. population in 2015 and the estimated 
population in 2050 was calculated to determine the excess population in 2050.  
This excess population was then distributed among urban counties only, based 
on U.N. projections of increased urbanization and numerically static rural 
populations within the United States through the twenty-first century.  Mid-sized 
cities are projected to sustain the greatest population growth (as a percentage) 
throughout the twenty-first century, with large and small cities sustaining 
moderate growth.  Based on these predictions, the excess population was 
distributed as follows:  30% of the excess was distributed to the upper 20% of 
urban counties by population density; 55% of the excess was distributed to the 
middle 47% of urban counties; 12.5% of the excess was distributed to the lowest 
33% of urban counties; and, 2.5% of the excess was distributed to a small 
percentage of the rural counties with the greatest population density, to smooth 
the transition between urban and rural.  The cut points determining how to 
distribute the excess population were arrived at by an iterative process to 
achieve the desired pattern of population growth with respect to city size.  Once 
estimates of county population for 2050 were derived, the 2050 county 
population density was calculated by dividing the county population by the county 
land area (exclusive of water area).  The process was then repeated to generate 
estimates for 2070. 
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 Two-way interaction terms (exclusive of land cover) previously determined 
to be contributory to the model were included in the analysis: between average 
temperature and total annual precipitation, between average temperature and 
average minimum temperature, between average minimum temperature and 
population density, and between population density and total annual 
precipitation.   
3.3 Analysis 
The logistic regression model predicting the probability of at least one 
WNV report in a county, P(WNV), took the form: 
𝑃 𝑊𝑁𝑉 =  𝑒!1+ 𝑒! 
where 
𝑧 = 𝑏! + 𝑏!𝑥!!"!!! + 𝑏!"𝑥!" + 𝑏!"𝑥!" + 𝑏!"𝑥!" + 𝑏!"𝑥!" + 𝑏!"𝑥!"𝑥!" + 𝑏!"𝑥!"𝑥!"+ 𝑏!!𝑥!"𝑥!" + 𝑏!"𝑥!"𝑥!" 
and 𝑥! = 𝑙𝑎𝑛𝑑 𝑐𝑜𝑣𝑒𝑟 𝑐𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛,𝑎𝑠 𝑑𝑢𝑚𝑚𝑦 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠 𝑥!" = 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑡𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒 𝑥!" = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑡𝑒𝑚𝑝𝑒𝑟𝑎𝑡𝑢𝑟𝑒 𝑥!" = 𝑝𝑟𝑒𝑐𝑖𝑝𝑖𝑡𝑎𝑡𝑖𝑜𝑛 𝑥!" = 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 
A total of eight models were evaluated, corresponding to the four emissions 
scenarios in both 2050 and 2070. 
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Pre-analysis data manipulation was performed using the pandas library 
and NumPy extension of the Python programming language.  Model fitting 
utilized PROC LOGISTIC in SAS, with scored (output) data smoothed and 
mapped using ordinary kriging implemented in Python via the Pykrige library.  
Kriging uses the known values of locations (here, the probabilities of WNV 
reports at the internal points of counties) to linearly predict values at unknown 
points, based on the common assumption that the values for areas close to one 
another will tend to be more highly correlated than areas that are far apart.215  
Coefficients in the kriging equation, often referred to as kriging weights, are 
chosen to minimize the variance in predicted values.  The result is a map with a 
fully interpolated surface, such that every given point on the map has an 
associated value.  Choropleth mapping was used for visual depiction of the 
kriged model output, with blue representing low risk of WNV, green and yellow 
representing increasing degrees of intermediate risk, and red indicating the areas 
of highest risk.  
To provide context for interpreting the output of the models compared to 
the current-day model presented in Study One, maps were generated to show 
the changes in minimum temperature, average temperature, precipitation, and 
population density from present-day (baseline) to 2050 and from present-day 
(baseline) to 2070.  Baseline values for each predictor were calculated from the 
county-level data used to generate the model in Study One, averaged over the 
eight years of that study (January 1, 2007 through September 30, 2014) and then 
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over each individual state.  Percent change from baseline for the four emissions 
trajectories at two time points (2050 and 2070) were examined for precipitation 
and average temperature.  Absolute change was utilized for average minimum 
temperature, because some northern states yielded extremely large changes 
when baseline values fell close to zero degrees Fahrenheit.  Percent change in 
population density was evaluated from baseline to 2050 and from baseline to 
2070.  Choropleth maps of the results were produced using Google Fusion 
Tables. 
3.4 Results 
3.4.1 Changes in predictor variables from present-day 
Predicted changes in precipitation are most pronounced across the desert 
Southwest (particularly Arizona), in which rainfall is predicted to increase in both 
2050 and 2070 (Figures 7 and 8).  More modest increases are predicted for 
Oregon, with slight increases across the High Plains and Southeast.  The Upper 
Midwest and Northeast are predicted to have minimal change in rainfall, with 
slight decreases across the northernmost portions of the region.   
Average temperature is predicted to increase across almost the entire 
country in 2050 (Figure 9), with the exceptions of the Southwestern region 
(California and Arizona) in all emissions trajectories and the Intermontane West 
in the lowest and mid-range scenarios.  The Upper Midwest is expected to warm 
the most, with only slight increases along the Gulf Coast and Eastern seaboard 
in all but the highest emissions trajectory and more moderate increases in the 
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highest emissions scenario.  These trends become more pronounced in 2070 
(Figure 10), with the lower emissions trajectory closely resembling mid-range 
predictions from 2050.  The highest emissions trajectory is the only scenario in 
which even the Southwest shows substantial increases in temperature; this 
trajectory predicts markedly increased temperatures centered in the Upper 
Midwest, with temperature increases across the nation becoming concentrically 
less dramatic further away from this center.   
Projections for changes in average minimum temperature generally 
resemble those for average temperature (Figures 11 and 12), with the West 
Coast/Southwest seeing minimal change in all 2050 trajectories except the 
highest emissions scenario, and with the Upper Midwest predicted to have the 
greatest increases.  Across the country the predicted average minimum 
temperatures increase with increased emissions and with time, such that the 
highest emissions trajectory predicts markedly increased values in the upper 
Midwest and moderate increases across the rest of the country. 
States with both current low population density and a low percentage of 
urbanized population (Wyoming, Montana, North Dakota, Vermont) are predicted 
to have minimal increase in population density in 2050 and 2070 (Figure 13).  
States in which the population tends to be heavily concentrated in a few highly 
urban areas (California, New York, New Jersey, Illinois) are projected to have 
only modest increases in population.  The greatest increases in population 
density are expected to occur in areas in which the population is largely 
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distributed in small to medium-sized cities (New Hampshire, Nevada, Colorado, 
Florida, South Carolina, Texas, Washington state). 
3.4.2 Predictive mapping of West Nile Virus 
Choropleth maps of the predicted probability of West Nile Virus positive 
U.S. counties for the four IPCC AR5 emissions scenarios are presented in Figure 
14 (for the year 2050) and Figure 15 (for 2070).  The baseline map for the period 
2007–2014 is presented for comparison in Figure 4 from Study One. 
All predicted scenarios show the West Coast and Southwestern United 
States remaining the areas with the greatest probability of West Nile Virus 
reports, with areas of highest probability occurring around southern California 
and the Bay Area.  North-central Colorado, northwestern Washington state, and 
the very southernmost portion of Texas are also consistently at increased risk.  
The probability of West Nile Virus positive counties in the Northeast, centered on 
the seaboard, and in Michigan (exclusive of the Upper Peninsula) decreases in 
higher-emissions scenarios, becoming close to zero in the 2070 high-emissions 
trajectory.  The northern Plains and Mountain states have minimal predicted 
probability in all scenarios at both time points.   
3.4.2.1 Changes in 2050 from baseline (2007–2014) 
All emissions trajectories result in more pronounced areas of highest risk 
centered around southern California, the Bay Area, Puget Sound, and 
southernmost Texas (Figure 14).  Areas of more modest risk are seen to spread 
slightly in the West, Southwest, eastern Great Lakes, and the seacoast of New 
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England in all but the lowest emissions scenario.  All changes in the range and 
intensity of risk are relatively small. 
3.4.2.2 Changes in 2070 from baseline (2007–2014) and from 2050 
In 2070 (Figure 15), the highest emissions scenario results in most of the 
West Coast and Southwest being above the baseline risk in 2007–2014, but the 
“hot spots” become less prominent than in 2050, suggesting a widespread 
regional homogenization of the included risk factors, particularly population 
density.  Figure 13 shows a marked increase in population density across much 
of the West Coast and Southwest in 2070, which likely explains the widespread 
increase in risk above baseline, but California lags behind other states in the 
region in this respect, likely resulting in dampening of the southern California hot 
spot.  In addition, the highest emissions scenario in 2070 results in minimal 
change in both average temperature (Figure 10) and average minimum 
temperature (Figure 12) for California, but more pronounced increases in 
surrounding states, which also likely contributes to the observed pattern in the 
region.   
The Northeast under the lowest emissions trajectory shows a widespread 
moderate West Nile Virus risk compared to both baseline and 2050, but under 
the highest emissions scenario the entire Northeast is at minimal risk, including 
the consistently moderate-risk, at baseline and 2050, Mid-Atlantic states.  This 
finding may be due to the interplay between population density and climatologic 
variables.  In the 2070 lowest emissions trajectory, climatologic variables remain 
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relatively unchanged (Figures 8, 10, 12), allowing the predominant effect to be 
the increase in population density across the Northeast (Figure 13); whereas, in 
all other emissions scenarios—and particularly in the highest—the Northeast 
experiences more substantial changes in climate that temper or, in the highest 
emissions scenario, override the population density effect. 
3.5 Discussion 
 The present study applied climate predictions and population predictions 
for the contiguous United States in 2050 and 2070 to the model for WNV risk 
developed in Study One.  Despite advances in global climate models, climate 
predictions are still subject to substantial uncertainty, so four climate scenarios 
based on different carbon dioxide emissions trajectories were evaluated.216 
These four trajectories included two extreme scenarios—one with marked 
reductions in emissions and one with essentially logarithmic growth in 
emissions—bracketing two more likely mid-range scenarios.  This allowed the 
present study to provide informal bounds on expected future WNV risk around 
the more plausible mid-range emissions risk maps, somewhat analogous to a 
confidence interval surrounding a point estimate. 
The results of the present study indicate an expansion of WNV risk across 
the western United States in all future climate scenarios.  Neither runaway risk 
(e.g., high risk across the entire contiguous United States) nor complete 
eradication of risk was seen regardless of emissions scenario, which has 
potential implications for both the model and for public health.  However, 
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applicability of a model is only as good as the model itself, and the model used in 
this study was found to perform poorly in Study One, thus limiting its utility 
regarding prediction of future WNV occurrence.   
The results of the present study were compared with the findings of 
Harrigan et al. (2014), which used a similar suite of predictors and CDC WNV 
case data to assess and forecast WNV risk in the contiguous United States.97 
Although not perfectly overlapping with our studies, their model was developed 
using a similar timeframe (2003–2011 for Harrigan et al., 2007–2014 for Study 
One), and was subsequently used to predict WNV risk for comparable future 
timeframes (2050–2060 and 2080–2090 for Harrigan et al. [2014], 2050 and 
2070 for the present study) using an IPCC AR5 mid-range scenario equivalent to 
our mid-range scenarios. 
Our model with current climate conditions, as presented in Study One, 
showed fair concordance with the findings of Harrigan et al. (2014) but diverged 
substantially with respect to predictions based on future climate scenarios.  That 
study found that maximum temperature drove an increase in mid- to late-21st 
century WNV risk across all states bordering Canada, whereas the present study 
showed an increase in risk only in the westernmost portion of that range.  In our 
model, maximum temperature was not found to be a significant predictor of WNV 
reports and hence was not included.  Moreover, the HealthMap data used to 
formulate the model were shown in Study One to systematically underestimate 
WNV occurrence across much of the northern United States.  It may be that 
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maximum temperature dropped out of our model for precisely this reason: cases 
were not recorded in the region where WNV occurrence was most strongly driven 
by maximum temperature.  Re-evaluating the model with maximum temperature 
included is therefore unlikely to provide significant enhancement of the model’s 
predictive ability, because the relationship we would be seeking to capture does 
not exist in the WNV report data used to formulate the model.   
 Our model also diverged from Harrigan et al. (2014) in a broad strip of the 
Southeastern United States, from western Oklahoma through the coastal 
Carolinas.  No change in risk was seen in our study, whereas WNV risk was 
predicted to increase in their study largely due to a decrease in precipitation.  
Unlike the difference noted in the northern tier of states, these discordant results 
may not be due to a difference in model quality, but rather to a different choice of 
climate baselines for comparison.  Harrigan et al. (2014) used a 30-year average 
from 1950–2000, whereas we used the period from 2007–2014.  During a 
substantial portion of the 2007–2014 period, the Southeast experienced 
historically severe drought, particularly compared to 1950–2000.217  Thus, while 
the Southeast is predicted to have reduced precipitation in the mid- to late-21st 
century compared to the long-run averages in 1960–1990 used by Harrigan at al.  
(2014), fairly minimal change in precipitation would be expected compared to 
2007–2014.  Using climate conditions from a period in which the United States 
actually experienced cases of WNV, rather than a historical average when WNV 
was not present in the country, was chosen in the present study to make the 
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interpretation of changes in risk more readily interpretable.  
 The highest risk area identified in the United States, both in the present 
and in 2050 and 2070, is Southern California.  This is consistent in both our study 
and Harrigan et al. (2014).  However, in the highest emissions scenario for 2070, 
there is a regional homogenization of risk across the Southwest.  Evaluation of 
the model predictors suggests that the homogenization may be a combination of 
lesser increases in population, average temperature, and minimum temperature 
for Southern California relative to surrounding areas.  However, another 
possibility is that the predicted climatic conditions of the high emissions scenario 
in 2070 fall outside the bounds of what was considered in formulating the model.  
In particular, non-linear relationships might exist that are only revealed at values 
outside the range of those used for model formulation.  Table 4 shows the mean, 
minimum, and maximum values for the continuous predictor variables for 2007–
2014 and the four emissions scenarios in 2050 and 2070.  Excluding population 
density, all values for future predictions fall within the range of current values, 
except for the highest emissions scenario in 2070 where the maximum values for 
average temperature and minimum temperature for 2070 exceed those for the 
baseline of 2007–2014.  This occurrence would seem to support the idea that 
out-of-range data are leading to a loss of predictive fidelity, but it is unclear if the 
extent to which they fall outside the current range is large enough to encounter 
potential non-linearity.  The increase in the maximum value for minimum 
temperature is only 0.28° Fahrenheit, which represents a 0.46% increase over 
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baseline; for average temperature, the increase is even smaller at 0.12° 
Fahrenheit, or 0.15% above baseline.  For population density, non-linearity is 
certainly possible, since the manner in which future population was estimated 
meant population density would at a minimum stay the same (for rural counties) 
or increase (for urban counties).  However, this non-linearity alone could not 
account for the homogenization of risk across the Southwest in the highest 
emissions scenario, since population was the same for all emissions scenarios in 
a given year. 
 It is important to note that, while climate is predicted to change 
substantially in the future, it is not surprising that the range of future values for 
climate predictors most often fall within the range of the present-day data used 
for model development.  The current values should more appropriately be viewed 
as meteorological and, hence, subject to substantial interannual variation.  This is 
in contrast to the climate variables in the future analyses, which represent an 
average that, while potentially substantially different from current averages, is 
unlikely to fall outside the extremes of current variation.   
One risk of modeling future phenomena is that, as previously noted, 
extreme inputs to the model might introduce effects not seen under the 
conditions on which the model was formulated.  Similarly, other important inputs 
or effects that act primarily at the extremes of the predictors might not be 
incorporated into the model correctly (or at all).  A predictor might have an 
apparently linear effect on the outcome until a certain threshold is exceeded, at 
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which point the nature of the relationship changes, or a variable might only be a 
significant predictor at the limits of its range.  Either circumstance could lead to 
inappropriate conclusions.  In some circumstances, this might lead to extinction 
of signal or a runaway signal.  While this may sometimes be accurate, for 
example in the context of a pandemic in a naïve population, such findings should 
raise questions about whether the model is erroneous.  That the four emissions 
trajectories produce generally concordant results, with discernable trends as 
emissions increase, offers some reassurance that the model is stable within the 
range of plausible inputs.   
From a public health perspective, the model indicates that surveillance 
programs, preventive measures, and resources needed to respond to a high 
WNV caseload should be concentrated in the western United States, particularly 
in the Southwest.  While the disease will likely remain endemic across the 
country, the greatest impact on the national WNV disease burden can be 
expected to be achieved by concentrating resources in this region.  This 
prediction may be helpful in designing more targeted approaches to vector 
control (e.g., mosquito spraying), surveillance of vectors (e.g., mosquito 
trapping), and surveillance of amplifying hosts (e.g., avian necropsy surveys).  
Model findings may also be useful for developing regional variations in the 
diagnostic algorithm for human cases of febrile illness, the diagnostic algorithm 
for neurologic disease in horses, and vaccination recommendations for horses.   
Models like the one in this study may also have an effect on efforts to 
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develop and test human WNV vaccines.  If models show waning risks of WNV in 
the coming decades, scarce public health resources may be better directed to 
combatting other diseases.  Conversely, the regionally widespread risk shown in 
our model may serve to emphasize the need for timely development of an 
effective vaccine.  Should future research produce a human WNV vaccine, 
knowing the locations most likely to be affected can inform supply chain logistics 
well in advance, and knowing the population of those areas may impact the 
amount and pricing of vaccine produced.  These latter points have broader 
implications.  Over-allocation of resources to produce vaccine for one disease 
can adversely impact the production of other medications or biologics of public 
health import, while under-allocation might prevent sufficient vaccine from being 
produced to provide adequate population-wide protection.218  Knowing the pricing 
of the vaccine well ahead of time may permit public health authorities to submit 
funding requests that incorporate this information, rather than diverting funds 
from other important disease programs. 
This study has several limitations, chief among them the fact that it is 
based on a model that poorly replicated HealthMap data in Study One.  Given 
that HealthMap data are an attempted approximation of gold-standard CDC case 
counts of WNV, and that a part of the model failure may be related to marked 
regional differences in HealthMap’s ability to capture this information, the results 
of the model are essentially two imperfect steps away from the ideal situation of a 
model that accurately replicates HealthMap data and in turn accurately reflects 
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CDC data.  Strategies to better capture the relationship between meteorological 
variables and HealthMap reports might include investigation of other variables 
(e.g., humidity), investigation of the shape of the predictor-outcome relationships 
via general additive models, and utilization of modeling techniques that take 
spatial and temporal correlation into account (e.g., conditional autoregressive 
modeling using the variable forms derived from general additive models).193,219  
However, none of these approaches address the discrepancies between 
HealthMap and CDC data.  It may be that the utility of HealthMap is as a real-
time indicator of areas of concern for directing deployment of short-term 
resources in well-publicized outbreaks, not as a reliable data source for modeling 
endemic disease dynamics.   
A second limitation is the number of assumptions that were made in the 
formulation of this model, which are shown in Table 5.  Some are discussed in 
more detail in Study One.  One assumption of concern is that the period of 2007–
2014 acts as a reasonable baseline for comparison with future climate.  Such a 
narrow window may be susceptible to short-term (meteorological) effects that 
obscure long-term climate trends.  Using a more historical average for 
comparison would eliminate this concern—the Southeast would have a much 
wetter historical baseline, for example—but would, as previously noted, result in 
difficulty interpreting the model output.  A change in risk of WNV in 2050 
compared to what the average risk would have been in the period between 
1950–2000 had WNV been present in the country, has very little intuitive 
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meaning.  An increase in risk from what was actually experienced in 2007–2014 
is more readily interpreted. 
Another assumption used in the model is that the distribution of mosquito 
vectors is constant through 2070 and spans the entire contiguous United States.  
It is possible that vector control methods will improve in the future to the point 
that entire regions become free of certain mosquitos and the diseases they 
transmit.  There are programs in development to reduce or eliminate mosquito 
populations not involved in WNV transmission using genetically modified males, 
similar to the highly effective eradication of screwworm myiasis (Cochliomyia 
hominivorax) from North America.220,221  While it is plausible that a similar 
program might be developed for Culex spp., this type of disruptive development 
is not readily incorporated into long-run models, and it is unclear if such 
widespread eradication is technically feasible or ecologically desirable.  In a 
similar way, development and widespread use of an effective human WNV 
vaccine would perturb the disease ecology substantially, but cannot be readily 
incorporated into the model. 
A third assumption is that land cover remains static from 2011 through 
2070, since land cover from 2011 is used for all model runs in this study.  This 
assumption is demonstrably untrue, but is justified by evaluation of the 
percentage change in land cover between 2001 and 2011, which was under 
three percent.222  Two-thirds of that change involved loss of deciduous and 
evergreen forest (56,533 square kilometers) and gain of an equal area of 
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shrubland, scrubland, and grassland/herbaceous land (52,812 square 
kilometers).  All of these land cover categories were found to exert a protective 
effect, so the country-wide impact on risk is close to zero.  Moreover, the majority 
of the increase in grassland/herbaceous land, shrubland, and scrubland was 
from land previously covered by forest, indicating that on a local scale most land 
change was a protective-for-protective swap and hence would exert minimal 
influence on WNV risk.222  Thus, much of the already small change in land cover 
per decade would have negligible impact on a local or country-wide level.  Rates 
of land cover change were relatively consistent comparing the periods of 2001–
2006 and 2006–2011, and there are no strong indicators that rates are likely to 
accelerate in the future, particularly as population growth slows.112 
The decision to use land cover as a static variable was also based on a 
lack of reliable predictions of future land cover.  In the absence of such 
predictions, the two options were excluding the variable from the analysis or 
including it based on a small per-decade rate of change.  Given the already poor 
performance of the model, retention of factors that improve discrimination was 
weighted more heavily than the expected minimal misclassification of exposure 
introduced by inclusion of the static variable.  Conversely, socioeconomic factors 
that may play a role in WNV occurrence were not incorporated because they are 
similarly lacking in reliable future predictions, but appear prone to substantial 
changes across the United States in the coming decades. 
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In conclusion, while the model in this study provides only a limited picture 
of the future impacts of West Nile Virus based on projections of climate change 
and population density, it does highlight the utility of this approach in the 
assessment of vector borne diseases and provides avenues for further model 
development.  Model-based techniques for vector borne disease impact 
assessment and mitigation are likely to gain increasing prominence in the public 
health toolkit as modeling methods are refined and become more widely 
employed.   
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Table 4.  Comparison of West Nile Virus predictor variable mean, minimum, and maximum values between present day, 
2050, and 2070, by emissions scenario   
Year and emissions 
scenario 
2007–2014 2050 
Lowest 
2050 Mid-
range 1 
2050 Mid-
range 2 
2050 
Highest 
2070 
Lowest 
2070 Mid-
range 1 
2070 Mid-
range 2 
2070 
Highest 
Population 
density/sq km 
         Mean 1.01 1.25 1.25 1.25 1.25 1.34 1.34 1.34 1.34 
Minimum 0.0004 4E-04 0.0004 0.0004 0.0004 0.0004 0.0004 0.0004 0.0004 
Maximum 277 324 324 324 324 344 344 344 344 
Minimum 
temperature, °F  
         Mean 20.71 24.91 25.41 25.14 26.25 24.02 25.74 25.26 28.75 
Minimum -15.30 -5.44 -3.82 -5.44 -3.64 -7.24 -3.28 -5.08 0.68 
Maximum 60.70 59.18 59.00 58.64 59.90 58.64 59.36 59.54 60.98 
Average 
temperature, °F 
         Mean 55.05 57.21 58.07 57.49 59.14 56.93 58.73 58.62 61.07 
Minimum 33.20 33.98 35.24 34.52 36.32 33.80 35.42 35.96 38.30 
Maximum 80.30 76.82 77.72 77.18 78.62 76.64 78.08 78.44 80.42 
Precipitation, inches 
         Mean 37.82 38.67 38.89 39.60 40.02 39.32 39.62 39.79 40.84 
Minimum 0.37 2.48 2.32 2.48 2.32 2.32 2.40 2.36 2.52 
Maximum 138.70 104.88 102.20 105.98 103.74 103.82 106.26 102.36 104.69 	
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Table 5. Assumptions made in formulating the model used to predict WNV reports 
Assumption Potential pitfalls Justifications 
Logistic regression as 
the best form to model 
the relationship 
between predictors and 
WNV reports 
Loss of information that could 
be retained in count-based 
modeling methods 
Structure of HealthMap data 
would result in substantial over- 
and undercounting in many 
counties if using count-based 
data 
No correlation in WNV 
reports by year 
Inappropriately small 
standard errors resulting in 
potential retention of non-
significant predictors; 
inappropriately narrow 
confidence intervals for odds 
ratio estimates of predictors 
Not all years show correlation in 
a random effects model; No 
SAS procedure available that 
could simultaneously account for 
correlated data and score 
additional input datasets 
No spatial 
autocorrelation 
Inappropriately small 
standard errors resulting in 
potential retention of non-
significant predictors; 
inappropriately narrow 
confidence intervals for odds 
ratio estimates of predictors 
Non-spatial logistic regression 
has been previously shown to 
be highly predictive of VBD 
(Wang et al. 2014); no explicit 
spatial logistic regression 
technique in SAS 
Mosquito vector 
distribution can be 
omitted as a predictor 
Loss of an informative 
exposure-outcome 
relationship that might 
improve model performance 
Only available as 
presence/absence data; present 
across virtually the entire study 
area; future predictions would 
depend on the same variables 
used to predict future WNV 
reports 
2007–2014 is an 
appropriate baseline for 
future comparisons 
Comparing models based on 
meteorological predictors to 
those using climate 
predictors, obscuring long-
term trends 
Long-run historical baselines 
incorporate periods in which 
WNV was not present, making 
interpretation of changes in risk 
non-intuitive; allows for direct 
comparison with Study One 
No future vaccine 
development 
Vaccine development would 
likely substantially reduce 
risk 
Difficult to predict if or when a 
vaccine will become available; 
difficult to predict efficacy 
No future 
improvements in 
mosquito vector control 
Improved vector control 
would likely substantially 
reduce risk 
Difficult to predict if or when 
vector control might improve; 
difficult to predict efficacy; 
possible vector shifting 
No changes in land 
cover between 2011 
and 2070 
Misclassification of exposure 
with respect to land cover 
Land cover historically changes 
at <3% per decade, and the 
majority of changes would have 
minimal impact on WNV risk; no 
reliable future predictions of land 
cover  
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Population growth will 
be highest in mid-sized 
cities and stagnant in 
rural areas 
Potential mis-estimation of 
future population density 
resulting in mis-estimation of 
WNV risk 
The predicted population 
structure follows established 
long-term trends; good track 
record of population predictions 
by the United Nations 
Relatively constant 
naïve/immune 
proportions in human 
and avian populations 
Immunity often increases 
with time, reducing the risk of 
disease 
WNV well-established in the 
study area by the time period 
used for model formulation; 
similar seroprevalences noted in 
the United States compared to 
areas of long endemicity 
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Figure 7.  Percent change from baseline (2007–2014) for United States annual precipitation in 2050, by emissions 
trajectory scenario 
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Figure 8. Percent change from baseline (2007–2014) for United States annual precipitation in 2070, by emissions 
trajectory scenario   
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Figure 9.  Percent change from baseline (2007–2014) for United States mean temperature in 2050, by emissions 
trajectory scenario 
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Figure 10.  Percent change from baseline (2007–2014) for United States mean temperature in 2070, by emissions 
trajectory scenario 
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Figure 11.  Absolute change from baseline (2007–2014) for United States mean minimum temperature in 2050, by 
emissions trajectory scenario 
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Figure 12.  Absolute change from baseline (2007–2014) for United States mean minimum temperature in 2070, by 
emissions trajectory scenario 
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Figure 13.  Percent change from baseline (2007–2014) for United States population density in 2050 and 2070 
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Figure 14.  Predicted probability of human West Nile Virus reports in the United States in 2050, by emissions 
trajectory scenario   
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Figure 15. Predicted probability of human West Nile Virus reports in the United States in 2070, by emissions 
trajectory scenario   
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4. Precipitation as a risk factor for development of Lyme nephritis in 
domestic dogs 
4.1 Introduction 
 Lyme disease was identified in the 1970s as an outbreak of 
arthritis/polyarthropathy, typically preceded by a rash, in humans in 
Connecticut.223  The causative organism was identified as a spirochete in 1982 
and was subsequently named Borrelia burgdorferi.224,225  The disease is 
transmitted via ticks of the Ixodes genus, and in the eastern United States the 
competent vector is Ixodes scapularis.223,226  B. burgdorferi is transmitted 
transstadially (i.e., from one life stage to the next) in this vector and is maintained 
in reservoir populations that include the white-footed mouse (Peromyscus 
leucopus).227–231  The preferred host of I. scapularis is the white-tailed deer 
(Odocoileus virginianus), such that I. scapularis populations tend to be closely 
correlated with deer populations.232,233  Tick abundance, survival, and feeding 
behavior have been demonstrated to be associated with meteorological 
conditions.41,234  Relative humidity, for example, has been shown to influence I. 
scapularis populations, with increasing humidity leading to greater numbers of 
ticks.235   
 In the 1980s, a number of dogs in Lyme-endemic areas were found to 
develop a polyarthropathy, which was soon identified as Lyme disease.236,237  
Only a small proportion of infected adult dogs develop signs of disease; younger 
dogs (6–26 weeks) tend to develop a self-limiting lameness in the limb closest to 
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the site of tick attachment 2–5 months after infection.238,239  All dogs are found to 
be persistently infected at the site of inoculation even after one year, and 
antimicrobials do not routinely eliminate the bacterium.238  Unlike humans, dogs 
rarely exhibit cutaneous reactions (the classic “bulls-eye” rash), making it difficult 
to determine the time of inoculation in naturally infected dogs.238  Current 
methods of diagnosis include a membrane-bound enzyme-linked immunosorbent 
assay (ELISA) and a quantitative ELISA for antibodies directed against the Lyme 
C6 antigen.240,241  Lyme C6 antibody concentrations tend to correlate with 
disease severity, decrease with antibiotic treatment, and are generally negative 
until four weeks after infection, peaking and remaining relatively constant six 
weeks following infection.242  This 4–6 week timeframe is significant in that 
clinical disease is typically not anticipated prior to one month post-infection.238 
 In 1997, a syndrome of severe protein-losing nephropathy (PLN) was 
noted in several Lyme-positive dogs.113  This Lyme nephropathy appears to 
affect primarily Labrador and Golden Retrievers, although all breeds and mixed 
breed dogs can be affected.113,243  Approximately 25% of affected dogs display a 
polyarthropathy shortly before the onset of renal disease.116  Other clinical signs 
generally relate to renal disease, lethargy, anorexia, vomiting, malaise, and 
polyuria/polydipsia frequently being seen.116  Kidney biopsies have found most 
cases to be due to a membranoproliferative glomerulonephritis with variable 
degrees of tubular necrosis and interstitial nephritis.113  Most immunostaining and 
elution studies on biopsy specimens have indicated some degree of Lyme 
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antigen-antibody complex deposition in the glomerular basement 
membrane.114,115   
 Definitive identification of cases has proved to be difficult, in part because 
Lyme seropositivity can be remarkably high in endemic regions, raising concerns 
that some seropositive results are merely coincidental in non-Lyme-associated 
cases of PLN in these regions.244  A model of Lyme nephritis has not been 
identified, precluding targeted studies, and Lyme nephritis appears to be 
extraordinarily rare in humans.245–248  Further complications arise from the fact 
that leptospirosis is a major differential diagnosis for dogs with Lyme nephritis, 
and the gold standard for diagnosis of leptospirosis is of questionable 
sensitivity.249  In addition, a number of other diseases are transmitted by Ixodes 
ticks, including anaplasmosis, bartonellosis, and babesiosis, occasionally 
resulting in co-infections; the contribution of these other agents is unclear.250,251  
Finally, full diagnostic evaluation to rule out other causes and to define the 
disease at a microscopic level (i.e., kidney biopsy) is often hampered by lack of 
financial resources or by failure to refer to suitably equipped facilities, resulting in 
poor diagnostic specificity.  Even the most basic case definition—“a history of 
exposure (i.e., positive serology), clinical findings consistent with PLN, and ruling 
out other causes”—is rarely fulfilled for these reasons.116   
 The aim of Study Three is to determine whether increased precipitation in 
the months prior to diagnosis is predictive of Lyme nephritis in dogs.  The choice 
of precipitation as the variable of interest was made because it is readily, widely, 
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and accurately measured; has biologic plausibility as a risk factor, due to the 
influence of precipitation on leaf litter humidity which is a strong predictor of I. 
scapularis populations; and, is readily noted by pet owners and veterinary 
clinicians.235  If precipitation is found to be a significant predictor of Lyme 
nephritis risk, this information could be used to develop targeted preventive 
recommendations and to improve diagnostic accuracy for Lyme nephritis.   
4.2 Methods 
4.2.1 Study Design 
 This study utilized a symmetrical bi-directional case-crossover 
design.252,253  This design identifies a “case hazard period” for each subject and 
compares that to “control hazard periods” at some interval(s) before and after the 
case hazard period.  The control hazard periods are intended to represent times 
when the outcome did not occur, providing the expected level of exposure.  The 
control period exposure level is compared to the exposure level at the time of the 
outcome.  The symmetrical bi-directional nature of control hazard period 
selection helps to minimize confounding introduced by temporal trends in 
unmeasured covariates.254   
 Two control hazard periods were chosen per case hazard period, one a 
year prior and one a year after the case hazard period to reduce confounding by 
season.  Including control hazard periods over multiple years before and after the 
case hazard period was considered but was rejected to conserve the number of 
cases eligible for the analysis.  If control hazard periods were required for two 
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years before and after the case period, it would exclude cases younger than two 
years old that were not at risk by virtue of not being born at the time of the 
earliest control hazard period, which is a particularly important consideration 
given the shortened lifespan of dogs.  Similarly, any case more recent than two 
years would be excluded, since exposure information would not be available for 
the two-year post-case control hazard period.  The result was a 1:2 matching of 
case to control hazard periods, separated by one-year intervals.   
4.2.2 Case Identification 
 Cases of canine Lyme nephritis were identified via a retrospective records 
search of the electronic medical records systems at the Tufts Cummings School 
of Veterinary Medicine’s Foster Hospital for Small Animals (North Grafton, MA) 
and Tufts Veterinary Emergency Treatment and Specialties (Walpole, MA).  Both 
institutions are university-affiliated tertiary referral hospitals with no routine or 
preventive services provided.  The initial search was conducted using the terms 
“Lyme nephritis” in any field, yielding 273 records between the years 2002 and 
2014.  Records were reviewed to remove duplicates, cases with a final diagnosis 
other than Lyme nephritis, and cases with insufficient information with respect to 
case status.  Patients younger than 18 months of age were excluded to ensure 
that cases were old enough to have been at risk of developing Lyme disease at 
the time of the first control period.  The case definition used was: any dog over 
the age of 18 months at the time of diagnosis with a documented protein-losing 
nephropathy, a positive Lyme antibody titer within one month of the diagnosis of 
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PLN, and exclusion of other appropriate differential diagnoses (refer to Appendix 
2 for the complete case definition algorithm). 
Uncorrected (i.e., not adjusted for urine concentration) proteinuria was 
assessed via urinalysis at one of two accredited veterinary reference laboratories 
(Idexx Laboratories, North Grafton, MA; Clinical Pathology Laboratory of the 
Tufts Cummings School of Veterinary Medicine, North Grafton, MA).  Proteinuric 
samples detected at Idexx Laboratories were confirmed via the sulfosalicylic acid 
precipitation assay.  Both laboratories perform routine microscopic evaluation of 
urine sediment to assess for the presence of red blood cells, white blood cells, 
uropathogens, crystals, and epithelial cells.  Urine protein to creatinine ratio 
testing was performed at the same reference laboratories using species-
validated automated biochemistry analyzers.  Aerobic urine culture was 
performed at Idexx Laboratories using standard microbiologic techniques. 
Point-of-care testing for Lyme disease utilized a species-validated, 
commercially available membrane-bound ELISA (SNAP 3Dx, SNAP 4Dx, or 
SNAP 4Dx Plus; Idexx Laboratories, Westbrook, ME).  Lyme C6 quantification 
was performed via a species-validated microtiter ELISA method at a commercial 
reference laboratory (Idexx Laboratories, North Grafton, MA).   
Renal biopsies were evaluated via light microscopy by board-certified 
veterinary anatomic pathologists, with immunostaining performed as deemed 
appropriate by the pathologist.  Renal/abdominal ultrasonography was performed 
by board-certified veterinary radiologists or board-certified veterinary internists.  
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Ultrasonography and histopathologic examination of renal biopsies were also 
performed by residents in radiology and anatomic pathology under the 
supervision of board-certified specialists.   
Information collected on each case included date of birth, date of 
diagnosis, sex, neuter status, and town of residence with ZIP code.  Birthdate 
was the date provided by the client (i.e., owner of the patient or authorized 
representative of the owner) on registration forms at the time of presentation to 
the hospital.  Date of diagnosis refers to the earliest date upon which kidney 
disease was documented via azotemia (i.e., blood urea nitrogen [BUN] 
concentration and serum creatinine concentration above the upper limit of the 
established reference range) or proteinuria.  Date of symptom onset was not 
used due to perceived inaccuracies in client reporting, clinician recording, or 
both.  Age at diagnosis was determined by the difference between the date of 
diagnosis and birthdate.  Sex was recorded as female or male, and neuter status 
was defined as either intact (for females, no known history of ovariohysterectomy 
or ovariectomy and absence of a compatible ovariohysterectomy scar; for males, 
presence of testes or a known state of cryptorchidism) or neutered (for females, 
a known history of ovariohysterectomy or ovariectomy, or a compatible 
ovariohysterectomy scar with absence of heat cycles; for males, a history of 
orchiectomy, or absence of testes and no known cryptorchidism).  Place of 
residence was defined as the municipality and associated five digit ZIP code 
provided by the client on the hospital registration form.   
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4.2.3 Creation and Definition of Precipitation Variables 
 Precipitation data were obtained from records maintained by the 
Massachusetts Department of Conservation and Recreation’s Rainfall Program, 
which records monthly precipitation totals from approximately 150 monitoring 
stations across Massachusetts (http://www.mass.gov/eea/agencies/dcr/water-
res-protection/water-data-tracking/rainfall-program.html).  Total monthly 
precipitation is reported in inches to the nearest tenth or hundredth, with rainfall 
measured via standard calibrated rain gauges and with other forms of 
precipitation (sleet, hail, snow) recorded by first melting the precipitation.   
 Each case ZIP code centroid (i.e., the geographic center of the ZIP code 
area) was linked to the geographically closest precipitation monitoring station ZIP 
code centroid using the Vincenty formula as implemented in SAS.171  
Precipitation data for the case and control hazard periods were then manually 
extracted from the records of the geographically closest station.  When 
precipitation data were lacking for the closest station for a given case hazard 
period, data from the next closest monitoring station were used.  Precipitation for 
control hazard periods with no precipitation data available from the closest 
monitoring station were set to missing if only one control hazard period for a 
given case had missing data; if both control periods lacked precipitation data, 
then precipitation totals from the next closest station were utilized for both control 
periods and for the case hazard period.  Precipitation data were most commonly 
absent due to recording errors/unexplained brief gaps in the record or to 
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permanent closure of a monitoring station. 
The case and control hazard intervals were lagged by one, two, three, and 
four months from the month of diagnosis, based on the anticipated induction time 
and latency period derived from previous studies of Lyme disease in dogs.238,239 
4.3 Analysis 
Hazard ratios and 95% confidence intervals were calculated via 
conditional logistic regression in the PHREG procedure of SAS 9.3 (SAS 
Institute, Cary, NC) for each lagged hazard interval (one, two, three, and four 
months prior to diagnosis), yielding four separate analyses.  A base model with 
monthly precipitation as the sole predictor was evaluated initially, and then age 
was included as a covariate in a second set of models.  Neuter status, as one of 
the few candidate covariates in the medical record that might change between 
control and hazard periods, was not included because no subjects were noted to 
have undergone neutering during the study interval.   
To evaluate the effect of distance between the residence of the case and 
the location of the monitoring station, an age-adjusted sub-analysis was 
performed excluding cases in which the nearest precipitation station was greater 
than 30 miles from the residence of the case.  The rationale for this sub-analysis 
was to minimize the extent of exposure misclassification. 
4.4 Results 
Eighty-seven cases were identified, representing mixed breed dogs and 
24 pure breeds (Table 6).  Labrador retrievers (35.6%) and golden retrievers 
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(11.5%) were the most commonly represented purebreds, with 19 (21.8%) 
mixed-breed dogs.  Spayed females accounted for just over half of all cases 
(51.7%), followed by castrated males (29.9%), intact males (11.5%), and intact 
females (6.9%).  The median age was 5.79 years, with an interquartile range of 
3.08 years.   
Cases were diagnosed throughout the year, peaking in Spring (Figure 16).  
No apparent pattern was seen with respect to either day of the week (Figure 17) 
or year (Figure 18).  Seventy-six cases came from Massachusetts (87.4%), with 
seven (8.05%) from Connecticut, two (2.3%) from Rhode Island, and one each 
(1.15%) from New Hampshire and Vermont.  Within Massachusetts, the 
municipalities of Hopkinton and Franklin accounted for five cases (5.75%) each; 
Westborough had four cases (4.6%).  The geographic distribution of cases is 
shown in Figure 19.  Observed clustering of cases is likely related to the 
catchment area of the hospitals from which the cases were drawn rather than 
any geographic influence on either precipitation or Lyme nephritis.  
 4.4.1 Effect of Precipitation on Diagnosis of Lyme Nephritis 
Precipitation data were available for all case periods and for 94.7% of 
control periods.  Results of the unadjusted (univariate) and age-adjusted 
analyses are presented in Table 7.  In bold the unadjusted and adjusted 
analyses, precipitation at one, two, or four months prior to diagnosis was not 
associated with the development of Lyme nephritis.  However, at three months 
prior to diagnosis, increased precipitation appeared to be a risk factor for the 
103 
 
	
103 
development of Lyme nephritis.  In the unadjusted analysis, a hazard ratio of 
1.110 (95% confidence interval of 0.999 – 1.233) was observed, indicating an 
11% increase in the risk of developing Lyme nephritis per one inch of additional 
rainfall per month.  The age-adjusted analysis suggested a 12.5% increase in the 
hazard of a patient developing Lyme nephritis (hazard ratio 1.125, 95% 
confidence interval 1.009 – 1.254).   
Sub-analyses of the data restricted to the 82 cases within 30 miles of a 
precipitation monitoring station again showed similar results (Table 8), with 
increased precipitation at three months prior to diagnosis associated with an 
increase in the risk of Lyme nephritis (hazard ratio 1.147, 95% confidence 
interval 1.025 – 1.285) and no association at one, two, and four months prior to 
diagnosis.  The stronger association between precipitation and Lyme nephritis 
seen in this sub-analysis implies some misclassification of precipitation exposure 
in the full analysis.  This observation strengthens the inference that precipitation 
is a risk factor for Lyme nephritis, since reducing misclassification of exposure 
would generally be expected to shift the hazard ratio further from the null only if 
an association exists between the exposure and outcome in question. 
4.5 Discussion 
 The results of this study indicate that increased precipitation is a risk factor 
for the development of canine Lyme nephritis.  The study evaluated four potential 
hazard periods (one, two, three, and four months prior to the month of diagnosis) 
based on our current understanding of the latent/incubation period for clinical 
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manifestations of canine Lyme disease.238,239  The finding that the risk is 
increased three months prior to the time of diagnosis is therefore plausible from a 
disease ecology standpoint and identifies a hazard period that can inform future 
studies of environmental risk factors for canine Lyme nephritis.   
 While this study does not investigate the mechanism by which increased 
precipitation might increase the risk of Lyme nephritis, the answer likely is rooted 
in the ecology of Ixodes scapularis.  Tick populations and feeding behaviors, like 
those of most arthropod vectors, are highly susceptible to a variety of 
environmental factors, including temperature and relative humidity.41,234,235  
Several studies have found relative humidity at the level of forest floor leaf litter to 
be strongly associated with I. scapularis nymphal populations, with higher 
humidity resulting in larger numbers of nymphal ticks.234,255  Much of this 
relationship appears to be a direct negative effect of low humidity on nymphal tick 
mortality.  The negative effect of low humidity is significant because the nymphal 
stage, rather than larval or adult stages, is the stage most likely to transmit 
Borrelia burgdorferi to humans and dogs.  The bacterium cannot be transmitted 
from an adult tick to its offspring, so larval ticks are uninfected when they hatch 
and must acquire the bacterium by feeding on infected reservoir hosts, typically 
small rodents.256  These feedings provide the energy for the larvae to transition to 
nymphs.  Nymphal ticks, infected as larvae, are then most likely to transmit 
disease to humans and dogs due to a combination of more indiscriminate feeding 
preferences at this stage and small size.257  The latter makes detection of the tick 
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difficult before it has had sufficient time to transmit the disease.  Adult stages of 
the tick rarely transmit the disease to humans or dogs due to a strong feeding 
preference for white-tailed deer and a larger, easier to detect body size.258 
 Precipitation, rather than relative humidity at the level of the leaf litter, was 
investigated as a risk factor in this study.  The precise relationship between 
relative humidity of the leaf litter and precipitation as measured at official weather 
stations is complex and not fully elucidated.  However, precipitation and leaf litter 
relative humidity are strongly positively correlated.41,235  Since leaf litter relative 
humidity is not commonly measured and varies with the depth of leaf litter, soil 
type, forest type, and extent of forest canopy, precipitation was used as a proxy 
in this study.   
 The relationship between precipitation and the risk of canine Lyme 
nephritis can be used to develop targeted preventive recommendations (when it 
is most important to apply acaricidal products to dogs or yards, for example), and 
to inform clinical decision-making for veterinarians.  Clinician awareness of risk 
factors for a particular disease potentially increases the predictive value of 
diagnostic testing.  If meteorological conditions have been favorable for the 
development of Lyme nephritis in a given patient with PLN, then the prior 
probability of that disease is increased and the positive predictive value (PPV) is 
consequently increased.  A patient presenting with PLN three months after an 
unusually wet month may be more likely to trigger testing for Lyme disease, and 
a positive result may be more likely to indicate a true Lyme-associated 
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nephropathy.  Conversely, low-precipitation conditions in the relevant timeframe 
would decrease the PPV and might lead a clinician to be more skeptical of Lyme 
disease as the cause of a case of PLN, and perhaps prompt additional testing for 
other causes.   This is important in the context of treatment, since appropriate 
treatment for Lyme nephritis may differ substantially from that for a different form 
of PLN.259–261  It is also important for prognostic purposes, since Lyme nephritis 
tends to have a more rapidly fatal course when compared to other causes of 
PLN.116  While precipitation exposure alone is not going to be the deciding factor 
in determining if a given case of PLN is due to Lyme disease, it adds another 
piece of information that can increase or decrease the positive predictive value of 
Lyme testing in these cases.  
 Prior to this study, breed and age were the only known risk factors for the 
disease, with Labrador retrievers and golden retrievers being 6.4 and 4.9 times 
more likely to develop Lyme nephritis, respectively, and PLN in young dogs being 
slightly more likely to be Lyme-associated than in older dogs.113  The present 
study also found that 57% of Lyme nephritis cases occurred in these two breeds, 
with no other breed representing more than 3.5% of the total; the median age of 
5.79 years is consistent with previous studies as well.  The reason for the breed 
predisposition is unknown, although higher tick exposure and aberrant host 
immunologic responses have been posited.  Increased tick exposure might be 
attributable to the breeds being used for field trials or other outdoor work.  
However, other working/sporting breeds like border collies and pointer breeds 
107 
 
	
107 
would be expected to be similarly overrepresented.  Aberrant immunologic 
responses may be more plausible given that these breeds are overrepresented in 
polyarthropathic presentations of Lyme disease, in which much of the joint 
inflammation stems from the host response to the pathogen rather than to the 
pathogen itself.262  The effect of age on Lyme nephritis risk also may be a 
reflection of immunologic abnormalities.  Immune-mediated diseases most often 
affect young medium- to large-breed dogs, although these diseases also tend to 
have a female predisposition, which has not been noted for Lyme 
nephropathy.263  An alternative explanation is that the age effect may be 
mediated in part by the breed effect.  Labradors and particularly golden retrievers 
have a high incidence of malignant neoplasia, which tends to limit the lifespan of 
these breeds relative to other breeds, concentrating disease in a younger 
population.264   
This study utilized a symmetrical bi-directional (SBI) case-control 
methodology, in which each case served as its own control at a fixed interval 
before and after the event of diagnosis.254  Use of this design reduced the 
number of individuals needed for the study.  This is particularly important in 
veterinary studies, which typically include few subjects and hence have limited 
statistical power.  Use of the same dog as its own control also introduces a 
powerful mechanism for dealing with most confounding, as it eliminates the need 
to control for variables that might be included in other studies, such as breed.   
This elimination of confounding by study design holds true for most, but 
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not all, potential confounders.  Any subject characteristic that can change 
between the control hazard period and the case hazard period has the potential 
to introduce confounding.  Similarly, bias can arise from factors that have a 
seasonal or other oscillatory variation.  A dog with seasonal allergies is 
fundamentally not the same dog in pollen season as it is in midwinter.  
Unidirectional designs, which were the first development of case-crossover 
studies, can control for these relatively well with appropriate selection of control 
hazard period(s) (e.g., choosing a control hazard period in the same season of a 
preceding year).  However, this strategy will not control for bias from secular 
trends.  For example, if precipitation increased linearly on a year-by-year basis, 
then an unadjusted unidirectional case-crossover study would erroneously find 
that precipitation is positively associated with the risk of Lyme nephritis, given 
that disease would invariably occur in a wetter period compared to any prior 
control hazard period.  The SBI case-control design can control for this bias, 
since the effect of precipitation would appear reversed when looking at a control 
hazard period after the time of diagnosis.  For any roughly linear time trend, the 
effect in the pre-case control hazard period is counterbalanced by the effect in 
the post-case control hazard period.  Thus, the use of SBI offers increased 
precision and reduced bias due to time-related confounding when compared to a 
standard matched pair case-crossover utilizing a single pre-hazard control 
period.254   
This study appears to be the first example of a case-crossover study 
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applied to small animal (canine and feline) medicine.  In veterinary medicine 
more broadly, case-crossover studies have been used in only a very limited 
number of studies for diseases of cattle, swine, and horses.265–267  In light of the 
challenges common to most veterinary studies—limited numbers of subjects, 
limited information on covariates, limited information on general population 
characteristics, and limited funding—the case-crossover design may offer an 
appealing design for the study of transient risk factors for diseases with a well-
defined onset.  This study also represents a broadening of the application of the 
case-crossover design, which is typically used only for extremely acute 
outcomes: exacerbations of asthma, bone fractures, myocardial infarction, and 
fatal automobile accidents, for example.253,267–269  The findings suggest that the 
outcome does not necessarily need to be acute, provided two conditions are met: 
first, that the exposure of interest can be fit into a well-defined hazard window (a 
single month, in the present study); and second, that what Rothman (1981) calls 
the “empirical induction period,” or the combination of the induction and latency 
periods, is consistent in length.270  The first condition is crucial to the second: if 
the timing of the exposure (the hazard window) cannot be well confined, it is 
impossible to establish a consistent empirical induction period.  A consistent 
empirical induction period then allows for the exposure to be lagged from the 
actual time of disease detection.  Thus, it is not the acuteness of the disease that 
is important, but rather whether the disease consistently manifests (if based on 
the time of onset of clinical signs) or is diagnosed (if based on time of diagnosis) 
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at a fixed interval from the hazard window. 
In conclusion, the present study found that precipitation three months prior 
to the time of diagnosis is a risk factor for the development of canine Lyme 
nephritis, with increased precipitation resulting in increased risk.  These findings 
may provide useful information for accurate diagnosis of dogs with PLN and may 
guide future studies of risk factors for Lyme nephritis.  The methodology 
employed here demonstrates that case-crossover designs have utility beyond 
peracute conditions.   
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Table 6.  Characteristics of dogs diagnosed 
with Lyme nephritis, 2004–2014 (N=87) 
Breed N (%) 
Labrador retriever 31 (35.63) 
Mixed breed 19 (21.84) 
Golden retriever 10 (11.49) 
Dachshund 3 (3.45) 
Boxer 2 (2.30) 
Scottish terrier 2 (2.30) 
Dogo Argentino 1 (1.15) 
Australian shepherd 1 (1.15) 
Bernese mountain dog 1 (1.15) 
Bichon frise 1 (1.15) 
Briard 1 (1.15) 
Bullmastiff 1 (1.15) 
Cane corso 1 (1.15) 
Cairn terrier 1 (1.15) 
Cocker spaniel 1 (1.15) 
Chihuahua 1 (1.15) 
Collie 1 (1.15) 
French bulldog 1 (1.15) 
Greyhound 1 (1.15) 
German shepherd 1 (1.15) 
Havanese 1 (1.15) 
Maltese 1 (1.15) 
Papillon 1 (1.15) 
Pekinese 1 (1.15) 
Silky terrier 1 (1.15) 
Spitz 1 (1.15) 
Sex/Neuter Status N (%) 
Intact female 6 (6.9) 
Intact male 10 (11.5) 
Neutered female 45 (51.7) 
Neutered male 10 (11.5) 
Unknown 16 (18.4) 
Age N (%) 
0–1 0 (0) 
2–3 22 (25.3) 
4–5 28 (32.2) 
6–7 21 (24.1) 
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8–9 10 (11.5) 
10–11 3 (3.4) 
12–13 3 (3.4) 
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Table 7. Hazard ratios for association of precipitation with development of canine 
Lyme nephritis, by hazard period 
 Unadjusted models 
 
Age-adjusted models 
Hazard period HR 95% CI 
 
HR 
 
95% CI 
1 month 0.995 (0.896, 1.105) 0.996 (0.897, 1.106) 
2 months 1.007 (0.900, 1.127) 1.007 (0.900, 1.126) 
3 months 1.110 (0.999, 1.233) 1.125 (1.009, 1.254) 
4 months 1.032 (0.911, 1.168) 1.029 (0.909, 1.165) 
  
HR = hazard ratio, 95% CI= 95% confidence interval of the hazard ratio 
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Table 8.  Age-adjusted hazard ratios for 
association of precipitation with development 
of canine Lyme nephritis restricted to cases 
within 30 miles of a precipitation monitoring 
station, by hazard period  
Model HR 95% CL 
1 month 0.987 (0.887, 1.100) 
2 months 0.988 (0.876, 1.114) 
3 months 1.147 (1.025, 1.285) 
4 months 1.032 (0.911, 1.171) 
 
HR = hazard ratio, 95% CI= 95% confidence interval of the hazard ratio 
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Figure 19. Heat map of canine Lyme nephritis study cases (2004–2014) 
 
From patients presented to the Foster Hospital for Small Animals (North Grafton, 
MA; location indicated by the blue star) and Tufts VETS (Walpole, MA; location 
indicated by the black star) between 2002–2014.  Cases are aggregated by ZIP 
code; green indicates fewer cases, red indicates greater numbers of cases.  
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5. Conclusions 
 Despite substantial progress in reducing the VBD burden in the middle of 
the twentieth century, this diverse category of diseases has re-emerged in recent 
decades as a critical global public health threat.3  Previously well-controlled 
VBDs have resurged, numerous new VBDs have emerged, and previously 
regional diseases have become transnational.  The studies in this dissertation 
represent important areas of epidemiologic research for understanding the 
ecology of these diseases and preparing for the future.   
 The first study investigated whether HealthMap data for WNV in the 
contiguous United States could be accurately replicated in a model utilizing 
environmental and demographic inputs as predictors.  While this type of 
modeling is likely to become an ever-larger part of the epidemiologic toolkit, the 
model developed in this study showed poor ability to replicate the HealthMap 
data.  These findings may point to systematic shortcomings in HealthMap’s ability 
to capture disease reports via the Internet in a manner that meaningfully tracks 
with actual disease incidence and traditional surveillance techniques.  Future 
investigation might elucidate the mechanisms underlying the disparity between 
HealthMap and traditional surveillance methods, which could in turn facilitate 
improvements to Internet-based surveillance.  Identifying areas for improvement 
is a crucial step in developing reliable, accurate, real-time resources for disease 
monitoring, planning, and response. 
 Study 1 identified the annual average of the bias-adjusted average 
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monthly temperature and annual total precipitation as being inversely related to 
the risk of WNV reports, and annual bias-adjusted mean monthly minimum 
temperature and human population density as being positively associated with 
WNV risk.  Study 2 used projected future values of these variables within a 
logistic regression framework to predict the occurrence of WNV in the contiguous 
United States under four possible climate scenarios in 2050 and 2070.  The 
results suggest that Southern California will remain the area of greatest risk 
under all climate scenarios, but that unchecked carbon dioxide emissions may 
lead to a widespread increase in risk across much of the western United States.  
Given the uncertainty in future climate, the use of four scenarios helps to bracket 
the expected change in WNV risk.   
 The third study used a symmetric bi-directional case-crossover design to 
investigate precipitation as a risk factor for Lyme nephritis in dogs.  The age-
adjusted results indicate that each inch of precipitation is associated with a 
12.5% increase in the risk of Lyme nephritis.  Multiple hazard periods were 
investigated, with three months prior to diagnosis being identified as the relevant 
period.  If the finding is confirmed, precipitation would be  only the second known 
risk factor for the disease, and knowledge of this information may help improve 
clinical discrimination of true positives from all cases of PLN.  Identification of the 
appropriate hazard period may also aid in the investigation of additional risk 
factors.  In addition, the study describes new, broader criteria for selecting 
diseases or events amenable to study with the case-crossover design, to include 
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any outcome with a well-defined hazard period and a consistent empirical 
induction period. It also represents the first use of case-crossover methodology in 
companion animal medicine.  Given the limitations often encountered in 
designing and conducting studies in companion animal medicine — e.g., low 
case numbers, lack of covariate information, difficulty identifying appropriate 
control subjects, the case-crossover design appears to be a promising technique 
for future studies. 
 As both human and veterinary medicine struggle to face emerging and 
resurgent threats from VBDs, identification of environmental risk factors and 
modeling of disease dynamics will occupy a crucial and expanding role in public 
health and disease prevention.  The studies in this dissertation address these 
issues by investigating novel surveillance systems, demonstrating the benefits 
and weaknesses of predictive modeling, identifying new risk factors, developing 
new case definitions, and expanding the utility of the case-crossover design. 
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6. Appendix 1. Land cover classifications used in the National Land Cover 
Database (2006 and 2011) 
Open Water 
Perennial ice/snow 
Developed, open space 
Developed, low intensity 
Developed, medium intensity 
Developed, high intensity 
Barren land 
Deciduous forest 
Evergreen forest 
Mixed forest 
Shrubs/scrub 
Grassland/herbaceous 
Hay/pasture 
Cultivated crops 
Woody wetlands 
Herbaceous wetlands 
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7. Appendix 2. Case definition algorithm for dogs with Lyme nephritis  
I.  any dog over the age of 18 months at the time of diagnosis (18 months was 
chosen to ensure that the patient would have been old enough to potentially be 
at risk of developing Lyme disease at the time of the first control period) 
A. With a documented protein-losing nephropathy (PLN) if either: 
1. Inappropriate proteinuria for the given urine concentration (USG) 
on a conventional urinalysis (1+ protein or greater for a USG 
<1.020, 2+ or greater for 1.020≥USG<1.035, or 3+ or greater for a 
USG ≥10.35) with no other evidence of an active urine sediment 
(white blood cell count <5 cells/high-power microscopy field, OR 
negative urine culture)  
OR 
2. A urine protein to creatinine ratio of >0.5 
 AND 
B. With a positive Lyme antibody titer within one month of the diagnosis of 
PLN if either: 
  1. Positive point-of-care membrane-bound ELISA 
  OR 
  2. Quantitative anti-C6 Lyme antigen antibody titer >30 
 AND 
 C.  Exclusion of other appropriate differential diagnoses if either: 
1. Kidney biopsy with compatible histological, ultrastructural, and 
immunostaining results 
  OR 
2. Negative urine culture, compatible kidney ultrasound findings, 
negative leptospirosis titers/PCR, and genetic screening (when 
appropriate) 
  OR 
3. In patients with neither kidney biopsy nor appropriate screening 
for other differential diagnoses, cases were still included if either: 
   a. An extremely high C6 titer was documented (>150) 
OR 
b. The illness was preceded by classic shifting 
polyarthropathy within the month prior to diagnosis of PLN 
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